SGK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| O00141 | S252 | Sugiyama | SGK1 SGK | SQGHIVLTDFGLCKENIEHNsTtstFCGtPEyLAPEVLHKQ |
| O00141 | S255 | Sugiyama | SGK1 SGK | HIVLTDFGLCKENIEHNsTtstFCGtPEyLAPEVLHKQPYD |
| O00141 | S397 | Sugiyama | SGK1 SGK | sGPNDLRHFDPEFTEEPVPNsIGKsPDsVLVTAsVKEAAEA |
| O00141 | S404 | Sugiyama | SGK1 SGK | HFDPEFTEEPVPNsIGKsPDsVLVTAsVKEAAEAFLGFsYA |
| O00141 | S410 | Sugiyama | SGK1 SGK | TEEPVPNsIGKsPDsVLVTAsVKEAAEAFLGFsYAPPTDSF |
| O00141 | S422 | PSP | SGK1 SGK | PDsVLVTAsVKEAAEAFLGFsYAPPTDSFL___________ |
| O00141 | T254 | Sugiyama | SGK1 SGK | GHIVLTDFGLCKENIEHNsTtstFCGtPEyLAPEVLHKQPY |
| O00141 | T256 | Sugiyama | SGK1 SGK | IVLTDFGLCKENIEHNsTtstFCGtPEyLAPEVLHKQPYDR |
| O00141 | T260 | Sugiyama | SGK1 SGK | DFGLCKENIEHNsTtstFCGtPEyLAPEVLHKQPYDRTVDW |
| O00141 | Y263 | Sugiyama | SGK1 SGK | LCKENIEHNsTtstFCGtPEyLAPEVLHKQPYDRTVDWWCL |
| O00213 | S610 | EPSD|PSP | APBB1 FE65 RIR | LTILHQQTEAVLGECRVRFLsFLAVGRDVHTFAFIMAAGPA |
| O00468 | S738 | Sugiyama | AGRN AGRIN | CGSDGVTYSTECELKKARCEsQRGLYVAAQGACRGPTFAPL |
| O00512 | S104 | Sugiyama | BCL9 | GLKNGAGNGAKGKGKRERsIsADsFDQRDPGtPNDDsDIKE |
| O14617 | S658 | Sugiyama | AP3D1 PRO0039 | DERPRAVFHEEEQRRPKHRPsEADEEELARRREARKQEQAN |
| O14618 | S267 | Sugiyama | CCS | DGLTIWEERGRPIAGKGRKEsAQPPAHL_____________ |
| O14639 | S452 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | PtPsAEGyQDVRDRMIHRstsQGsINsPVySRHsYtPTTSR |
| O14686 | S1331 | SIGNOR|PSP | KMT2D ALR MLL2 MLL4 | RRRPRGGAHGGRGRGRARLKsTASSIETLVVADIDSSPSKE |
| O14920 | S181 | EPSD|PSP | IKBKB IKKB | IHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQKyTV |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O15111 | S180 | GPS6|EPSD | CHUK IKKA TCF16 | IHKIIDLGYAKDVDQGsLCTsFVGTLQYLAPELFENKPYTA |
| O15111 | T23 | GPS6 | CHUK IKKA TCF16 | RPPGLRPGAGGPWEMRERLGtGGFGNVCLYQHRELDLKIAI |
| O15530 | S176 | Sugiyama | PDPK1 PDK1 | YFGLSYAKNGELLKYIRKIGsFDETCTRFYTAEIVSALEYL |
| O43175 | T78 | Sugiyama | PHGDH PGDH3 | KVTADVINAAEKLQVVGRAGtGVDNVDLEAAtRKGILVMNT |
| O43318 | S439 | Sugiyama | MAP3K7 TAK1 | GNILDVPEIVISGNGQPRRRsIQDLtVtGTEPGQVssRsss |
| O43524 | S253 | SIGNOR|ELM|iPTMNet|EPSD | FOXO3 FKHRL1 FOXO3A | WWIINPDGGKsGKAPRRRAVsMDNsNKYTKSRGRAAKKKAA |
| O43524 | S315 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | PtSRssDELDAWTDFRsRTNsNAsTVsGRLSPIMAsTELDE |
| O43524 | T32 | SIGNOR|ELM|iPTMNet|EPSD | FOXO3 FKHRL1 FOXO3A | sPLEVELDPEFEPQSRPRsCtWPLQRPELQAsPAKPSGETA |
| O43707 | T69 | Sugiyama | ACTN4 | EKQQRKTFTAWCNsHLRKAGtQIENIDEDFRDGLKLMLLLE |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60271 | T595 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | NLKYNAPTSHVtPsVKKRsstLsQLPGDKSKAFDFLSEETE |
| O60343 | S318 | GPS6|PSP | TBC1D4 AS160 KIAA0603 | ERILEDsGFDEQQEFRsRCssVTGVQRRVHEGSQKSQPRRR |
| O60343 | S341 | PSP | TBC1D4 AS160 KIAA0603 | GVQRRVHEGSQKSQPRRRHAsAPsHVQPSDSEKNRTMLFQV |
| O60343 | S570 | PSP | TBC1D4 AS160 KIAA0603 | ssGRFKLDILKNKAKRsLtssLENIFSRGANRMRGRLGsVD |
| O60343 | S588 | GPS6|PSP|Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60343 | S666 | PSP | TBC1D4 AS160 KIAA0603 | PPsstKRKLNLQDGRAQGVRsPLLRQSssEQCSNLSSVRRM |
| O60343 | S751 | GPS6|PSP | TBC1D4 AS160 KIAA0603 | EIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRRIS |
| O60343 | T568 | GPS6|PSP | TBC1D4 AS160 KIAA0603 | AtssGRFKLDILKNKAKRsLtssLENIFSRGANRMRGRLGs |
| O60343 | T642 | GPS6|PSP | TBC1D4 AS160 KIAA0603 | AWQTFPEEDSDSPQFRRRAHtFsHPPsstKRKLNLQDGRAQ |
| O60716 | Y865 | Sugiyama | CTNND1 KIAA0384 | KKsDFQVNLNNAsRsQssHsyDDstLPLIDRNQKsDKKPDR |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S178 | Sugiyama | EIF5B IF2 KIAA0741 | NKKWDGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRK |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O75534 | S584 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | YSLSKGKGNKVSAEKVNKtHsVNGItEEADPTIysGKVIRP |
| O75665 | S899 | Sugiyama | OFD1 CXorf5 | EEKIREQQVKERRQREERRQsNLQEVLERERRELEKLyQER |
| O75717 | S374 | Sugiyama | WDHD1 AND1 | INDDEDDEDLMMAsGRPRQRsHILEDDENsVDIsMLKtGss |
| O75937 | S81 | Sugiyama | DNAJC8 SPF31 HSPC315 HSPC331 | VLQIDPEVTDEEIKKRFRQLsILVHPDKNQDDADRAQKAFE |
| O94763 | S372 | Sugiyama | URI1 C19orf2 NNX3 PPP1R19 RMP URI | KNTTLKFSEKKEEAKRKRKNstGsGHsAQELPTIRTPADIY |
| O95239 | S801 | Sugiyama | KIF4A KIF4 | LKEKKESGENPPPKLRRRtFsLtEVRGQVsEsEDsItKQIE |
| O95243 | S318 | Sugiyama | MBD4 MED1 | ETLSVTSEENSLVKKKERsLssGsNFCSEQKTSGIINKFCS |
| O95243 | S319 | Sugiyama | MBD4 MED1 | TLSVTSEENSLVKKKERsLssGsNFCSEQKTSGIINKFCSA |
| O95602 | T1373 | Sugiyama | POLR1A | SIKKKNNKASAFRNVNTRRAtQRDLDNAGELGRSRGEQEGD |
| O95757 | T637 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLSKLSAVLED |
| O95785 | S1094 | Sugiyama | WIZ ZNF803 | WYVNGsPIDTLREILKRRTQsRPGGPPNPPGPsPKALAKMM |
| O95835 | S464 | Sugiyama | LATS1 WARTS | SPSSGHEIPTWQPNIPVRsNsFNNPLGNRASHSANSQPSAT |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00491 | S163 | Sugiyama | PNP NP | GQNPLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGE |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04150 | S203 | SIGNOR | NR3C1 GRL | LYTTDQSTFDILQDLEFssGsPGKETNEsPWRSDLLIDENC |
| P04150 | S211 | SIGNOR | NR3C1 GRL | FDILQDLEFssGsPGKETNEsPWRSDLLIDENCLLsPLAGE |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P05023 | S519 | Sugiyama | ATP1A1 | sEPQHLLVMKGAPERILDRCssILLHGKEQPLDEELKDAFQ |
| P05023 | S520 | Sugiyama | ATP1A1 | EPQHLLVMKGAPERILDRCssILLHGKEQPLDEELKDAFQN |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05787 | S280 | Sugiyama | KRT8 CYK8 | IAEVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDL |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S315 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQL |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P08238 | S307 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P0CAP2 | T184 | Sugiyama | POLR2M GRINL1A | PSSEASEHHPRHRVssQAEDtSssFDNLFIDRLQRITIADQ |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10636 | S214 | GPS6|SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | GDLHQEGPPLKGAGGKERPGsKEEVDEDRDVDESsPQDsPP |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11274 | S371 | Sugiyama | BCR BCR1 D22S11 | SRVsPsPTTyRMFRDKsRsPsQNsQQsFDSssPPtPQCHKR |
| P11717 | S1951 | Sugiyama | IGF2R MPRI | ADYDRDHEWGFCRHSNSYRTssIIFKCDEDEDIGRPQVFSE |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13798 | S175 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | WSHSETHLLYVAEKKRPKAEsFFQTKALDVsAsDDEIARLK |
| P13798 | S27 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | LsEPEEAAALyRGLSRQPALsAACLGPEVtTQyGGQyRTVH |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P14672 | S274 | GPS6|SIGNOR|EPSD|PSP | SLC2A4 GLUT4 | SGVLAELKDEKRKLERERPLsLLQLLGSRTHRQPLIIAVVL |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P15056 | S365 | GPS6|ELM|iPTMNet|EPSD | BRAF BRAF1 RAFB1 | PFRPADEDHRNQFGQRDRsssAPNVHINtIEPVNIDDLIRD |
| P16220 | S119 | PSP | CREB1 | EsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVPRIEE |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17655 | T464 | Sugiyama | CAPN2 CANPL2 | TNIHLSKNFFLTNRARERsDtFINLREVLNRFKLPPGEYIL |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18858 | S901 | Sugiyama | LIG1 | DKQPEQATTSAQVACLYRKQsQIQNQQGEDsGsDPEDTY__ |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20810 | S366 | Sugiyama | CAST | DKDGKPLLPEPEEKPKPRsEsELIDELsEDFDRsECKEKPS |
| P21333 | S2152 | Sugiyama | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P21731 | S331 | Sugiyama | TBXA2R | FRRAVLRRLQPRLsTRPRsLsLQPQLtQRSGLQ________ |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23588 | S311 | Sugiyama | EIF4B | YRGGGDRYEDRYDRRDDRsWssRDDysRDDYRRDDRGPPQR |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25789 | S7 | Sugiyama | PSMA4 HC9 PSC9 | ______________MSRRyDsRttIFsPEGRLYQVEYAMEA |
| P25963 | S32 | EPSD|PSP | NFKBIA IKBA MAD3 NFKBI | AMEGPRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEI |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27816 | T828 | Sugiyama | MAP4 | AKtttAAAVAstGPssRsPstLLPKKPTAIKTEGKPAEVKK |
| P28482 | S29 | GPS6|SIGNOR|EPSD|PSP | MAPK1 ERK2 PRKM1 PRKM2 | AGPEMVRGQVFDVGPRYTNLsYIGEGAYGMVCSAYDNVNKV |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P30044 | S182 | Sugiyama | PRDX5 ACR1 SBBI10 | DLLLDDsLVsIFGNRRLKRFsMVVQDGIVKALNVEPDGTGL |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30086 | T51 | Sugiyama | PEBP1 PBP PEBP | GAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDP |
| P30626 | T170 | Sugiyama | SRI | tNGKItFDDyIACCVKLRALtDSFRRRDTAQQGVVNFPYDD |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42858 | S419 | SIGNOR|EPSD|PSP | HTT HD IT15 | GGIGQLtAAKEEsGGRsRsGsIVELIAGGGssCsPVLsRKQ |
| P43003 | T482 | SIGNOR|iPTMNet|EPSD | SLC1A3 EAAT1 GLAST GLAST1 | TDDITLIIAVDWFLDRLRTTtNVLGDSLGAGIVEHLSRHEL |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P45985 | S80 | EPSD|PSP | MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1 | tLNPNPtGVQNPHIERLRTHsIEsSGKLKIsPEQHWDFtAE |
| P46527 | T157 | SIGNOR|EPSD|PSP | CDKN1B KIP1 p27 | PsDsQTGLAEQCAGIRKRPAtDDSSTQNKRANRTEENVsDG |
| P46527 | T198 | SIGNOR|EPSD|PSP | CDKN1B KIP1 p27 | sPNAGSVEQtPKKPGLRRRQt____________________ |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P48048 | S44 | GPS6|ELM|EPSD | KCNJ1 ROMK1 | LRKWVVTRFFGHSRQRARLVsKDGRCNIEFGNVEAQSRFIF |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48764 | S663 | GPS6|EPSD | SLC9A3 NHE3 | TEDEKQDREIFHRTMRKRLEsFKSTKLGLNQNKKAAKLYKR |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P49753 | T118 | Sugiyama | ACOT2 PTE2 PTE2A | ASLRDEKGALFQAHARyRADtLGELDLERAPALGGSFAGLE |
| P49753 | Y114 | Sugiyama | ACOT2 PTE2 PTE2A | VTLRASLRDEKGALFQAHARyRADtLGELDLERAPALGGSF |
| P49792 | T3217 | Sugiyama | RANBP2 NUP358 | DTVKKIESFGsPKGSVCRRItITECGQI_____________ |
| P49815 | S1130 | SIGNOR|PSP | TSC2 TSC4 | AKLESQAGQQVSRGARDRVRsMsGGHGLRVGALDVPASQFL |
| P49815 | S1132 | SIGNOR|PSP | TSC2 TSC4 | LESQAGQQVSRGARDRVRsMsGGHGLRVGALDVPASQFLGs |
| P49815 | S1798 | PSP | TSC2 TSC4 | AQTPAEPTPGyEVGQRKRLIssVEDFTEFV___________ |
| P49815 | S939 | PSP | TSC2 TSC4 | NVLLsFDDtPEKDsFRARsTsLNERPKSLRIARPPKQGLNN |
| P49815 | S981 | PSP | TSC2 TSC4 | PPVKEFKESSAAEAFRCRsIsVsEHVVRSRIQTSLTsAsLG |
| P49815 | T1462 | PSP | TSC2 TSC4 | EGPLPsssPRsPsGLRPRGYtIsDsAPsRRGKRVERDALKS |
| P49840 | S21 | iPTMNet|EPSD | GSK3A | MsGGGPsGGGPGGsGRARtssFAEPGGGGGGGGGGPGGsAs |
| P49841 | S21 | ELM | GSK3B | MSGRPRttsFAEsCKPVQQPsAFGsMKVSRDKDGSKVTTVV |
| P49841 | S9 | PSP | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P49841 | Y216 | PSP | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50395 | S427 | Sugiyama | GDI2 RABGDIB | ttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED__ |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51946 | T12 | Sugiyama | CCNH | _________MYHNsSQKRHWtFSsEEQLARLRADANRKFRC |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P53365 | S260 | Sugiyama | ARFIP2 POR1 | TDLEELsLGPRDAGTRGRLEsAQATFQAHRDKYEKLRGDVA |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53602 | S231 | Sugiyama | MVD MPD | stVGMRASVETsPLLRFRAEsVVPARMAEMARCIRERDFPS |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P55884 | S119 | Sugiyama | EIF3B EIF3S9 | PPVPAQGEAPGEQARDERsDsRAQAVsEDAGGNEGRAAEAE |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| Q00587 | S192 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | PHDRDRDGsFPsEPGLRRsDsLLsFRLDLDLGPSLLSELLG |
| Q00987 | S166 | GPS6|EPSD|PSP | MDM2 | KPSSSHLVSRPstSSRRRAIsEtEENsDELsGERQRKRHKs |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02952 | S627 | Sugiyama | AKAP12 AKAP250 | VtPWAsFKKMVtPKKRVRRPsEsDKEDELDKVKsAtLsstE |
| Q04917 | S145 | Sugiyama | YWHAH YWHA1 | KMKGDYYRYLAEVASGEKKNsVVEAsEAAyKEAFEISKEQM |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q05682 | T546 | Sugiyama | CALD1 CAD CDM | GAPQVEAGKRLEELRRRRGEtESEEFEKLKQKQQEAALELE |
| Q06124 | S134 | Sugiyama | PTPN11 PTP2C SHPTP2 | HGHLSGKEAEKLLTEKGKHGsFLVREsQsHPGDFVLSVRTG |
| Q07866 | S524 | Sugiyama | KLC1 KLC KNS2 | QRVAEVLNDPENMEKRRsREsLNVDVVKYESGPDGGEEVSM |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q12778 | S256 | GPS6|ELM | FOXO1 FKHR FOXO1A | WWMLNPEGGKSGKsPRRRAAsMDNNSKFAKSRSRAAKKKAs |
| Q12778 | S319 | ELM | FOXO1 FKHR FOXO1A | PGsHsNDDFDNWSTFRPRtssNAstIsGRLsPIMtEQDDLG |
| Q12778 | S322 | GPS6 | FOXO1 FKHR FOXO1A | HsNDDFDNWSTFRPRtssNAstIsGRLsPIMtEQDDLGEGD |
| Q12778 | T24 | GPS6|SIGNOR|ELM|EPSD | FOXO1 FKHR FOXO1A | APQVVEIDPDFEPLPRPRsCtWPLPRPEFSQSNSATSSPAP |
| Q12931 | T494 | Sugiyama | TRAP1 HSP75 HSPC5 | ALPsGQLtsLsEyASRMRAGtRNIyyLCAPNRHLAEHsPyy |
| Q12965 | T936 | Sugiyama | MYO1E MYO1C | LQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAP |
| Q12965 | Y941 | Sugiyama | MYO1E MYO1C | GPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPPGy |
| Q12982 | S114 | Sugiyama | BNIP2 NIP2 | EFEWEDDLPKPKTTEVIRKGsItEyTAAEEKEDGRRWRMFR |
| Q13206 | S831 | Sugiyama | DDX10 | DMENKISDTKKKQGMKKRsNsEVEDVGPTsHNRKKARWDTL |
| Q13439 | S41 | Sugiyama | GOLGA4 | APAQAssNsstPtRMRsRtssFtEQLDEGtPNRESGDTQSF |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13501 | S28 | Sugiyama | SQSTM1 ORCA OSIL | AYLLGKEDAAREIRRFsFCCsPEPEAEAEAAAGPGPCERLL |
| Q13586 | S620 | Sugiyama | STIM1 GOK | sPsAPPGGsPHLDssRsHsPssPDPDtPsPVGDSRALQASR |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14204 | S3082 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | LHVVFTMNPSSEGLKDRAAtsPALFNRCVLNWFGDWSTEAL |
| Q14204 | S4368 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | MLEDEDDLAyAETEKKTRtDstsDGRPAWMRTLHTTASNWL |
| Q14432 | S312 | Sugiyama | PDE3A | sssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKRG |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14978 | S686 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | KGKSFRHEKTKKKRGsYRGGsIsVQVNsIKFDsE_______ |
| Q15149 | S4386 | Sugiyama | PLEC PLEC1 | ItEFADMLsGNAGGFRsRsssVGssssyPIsPAVsRtQLAs |
| Q15428 | S153 | Sugiyama | SF3A2 SAP62 | LFQIDYPEIAEGIMPRHRFMsAyEQRIEPPDRRWQYLLMAA |
| Q15599 | T102 | Sugiyama | NHERF2 SLC9A3R2 | QTRLLVVDQETDEELRRRQLtCTEEMAQRGLPPAHDPWEPK |
| Q15811 | S315 | Sugiyama | ITSN1 ITSN SH3D1A | LPPVLPPEYIPPSFRRVRsGsGIsVIsSTSVDQRLPEEPVL |
| Q15811 | S318 | Sugiyama | ITSN1 ITSN SH3D1A | VLPPEYIPPSFRRVRsGsGIsVIsSTSVDQRLPEEPVLEDE |
| Q15818 | S91 | Sugiyama | NPTX1 | TILSQKETIRELTAKLGRCEsQsTLDPGAGEARAGGGRKQP |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16637 | S28 | Sugiyama | SMN1 SMN SMNT; SMN2 SMNC | sGGGVPEQEDsVLFRRGtGQsDDsDIWDDtALIKAYDKAVA |
| Q3KQU3 | S112 | Sugiyama | MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 | KsRGPtPPAMGPRDARPPRRssQPsPtAVPAsDsPPtKQEV |
| Q53EL6 | S71 | Sugiyama | PDCD4 H731 | NEARINAKAKRRLRKNssRDsGRGDsVsDsGsDALRSGLtV |
| Q53EL6 | S76 | Sugiyama | PDCD4 H731 | NAKAKRRLRKNssRDsGRGDsVsDsGsDALRSGLtVPtsPK |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5JTD0 | S545 | Sugiyama | TJAP1 PILT TJP4 | ssRPQRsPKRMGVHHLHRKDsLtQAQEQGNLLN________ |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5SW79 | S881 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | sstPssLALtsAsRIRERsEsLDPDssMDTtLILKDTEAVM |
| Q5VT52 | S1180 | Sugiyama | RPRD2 KIAA0460 HSPC099 | TGFKTAPYKERAPQFQEsVGsFRsNsFNstFEHHLPPsPLE |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5VV41 | S208 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | HtRsPAKNKKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQ |
| Q6A1A2 | S149 | Sugiyama | PDPK2P PDPK2 | YFGLSYAKNGELLKYIRKIGsFDETCTRFYTAEIVSALEYL |
| Q6R327 | T1135 | EPSD|PSP | RICTOR KIAA1999 | PKGGKLSSESKTSNRRIRtLtEPsVDFNHsDDFtPISTVQK |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZN18 | S206 | Sugiyama | AEBP2 | DEGYGTGGGGSSATSGGRRGsLEMssDGEPLSRMDSEDSIS |
| Q71RC2 | S597 | Sugiyama | LARP4 PP13296 | QttIPVsPPsttKPsRAstAsPCNNNINAAtAVALQEPRKL |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q86T24 | T606 | PSP | ZBTB33 KAISO ZNF348 | LHPCRSLQIRQYAYLSDRSStIPAMKDDGIGYKVDTGKEPP |
| Q86TX2 | T56 | Sugiyama | ACOT1 CTE1 | ASLRDEKGALFQAHARyRADtLGELDLERAPALGGSFAGLE |
| Q86TX2 | Y52 | Sugiyama | ACOT1 CTE1 | VTLRASLRDEKGALFQAHARyRADtLGELDLERAPALGGSF |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86V48 | S996 | Sugiyama | LUZP1 | RRVGPSSGDAPEPSSRRtQssLtVSEVLTRRNRVGDTITVA |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBJ7 | T273 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | RGAsWIDtADGsANHRARVttRMGNtPDsAsDNLGFRCAAD |
| Q8ND56 | T384 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | DKTKsFFDNIsCDDNRERRPtWAEERRLNAETFGIPLRPNR |
| Q8TD19 | T333 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | REMEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYVWG |
| Q92542 | S437 | SIGNOR|EPSD|PSP | NCSTN KIAA0253 UNQ1874/PRO4317 | NQSQPLPPSSLQRFLRARNIsGVVLADHSGAFHNKYYQSIY |
| Q92558 | T105 | Sugiyama | WASF1 KIAA0269 SCAR1 WAVE1 | PKEEELSLQDITMRKAFRsstIQDQQLFDRKTLPIPLQETy |
| Q92597 | S330 | GPS6|SIGNOR|ELM|EPSD|PSP|Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q92597 | S332 | GPS6|EPSD | NDRG1 CAP43 DRG1 RTP | MGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGTRs |
| Q92597 | S364 | GPS6|EPSD|Sugiyama | NDRG1 CAP43 DRG1 RTP | sHtSEGTRsRsHtsEGtRsRsHtsEGAHLDItPNsGAAGNs |
| Q92597 | T328 | GPS6|ELM|EPSD|PSP | NDRG1 CAP43 DRG1 RTP | FVQGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSE |
| Q92597 | T346 | GPS6|SIGNOR|ELM|EPSD|PSP | NDRG1 CAP43 DRG1 RTP | sRtAsGssVtsLDGtRsRsHtSEGTRsRsHtsEGtRsRsHt |
| Q92597 | T356 | GPS6|SIGNOR|ELM|EPSD|PSP | NDRG1 CAP43 DRG1 RTP | sLDGtRsRsHtSEGTRsRsHtsEGtRsRsHtsEGAHLDItP |
| Q92597 | T366 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | NDRG1 CAP43 DRG1 RTP | tSEGTRsRsHtsEGtRsRsHtsEGAHLDItPNsGAAGNsAG |
| Q92766 | S1167 | Sugiyama | RREB1 FINB | AGTSKKRGRKRGMRSRPRANsGGVDLDssGEFASIEKMLAT |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q969H0 | S227 | GPS6|SIGNOR|EPSD|PSP | FBXW7 FBW7 FBX30 SEL10 | TTFGDLRAANGQGQQRRRITsVQPPTGLQEWLKMFQSWSGP |
| Q96B36 | T246 | Sugiyama | AKT1S1 PRAS40 | VLREAEDtQVFGDLPRPRLNtsDFQKLKRKY__________ |
| Q96G46 | T240 | Sugiyama | DUS3L | KREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPRQENC |
| Q96J92 | S1190 | EPSD|PSP | WNK4 PRKWNK4 | QPPPGIVAPAAMLSSRQRRLsKGSFPTSRRNsLQRSEPPGP |
| Q96J92 | S1201 | SIGNOR|EPSD|PSP | WNK4 PRKWNK4 | MLSSRQRRLsKGSFPTSRRNsLQRSEPPGPGIMRRNsLsGs |
| Q96J92 | S1217 | EPSD|PSP | WNK4 PRKWNK4 | SRRNsLQRSEPPGPGIMRRNsLsGsSTGSQEQRASKGVTFA |
| Q96JJ3 | S503 | Sugiyama | ELMO2 CED12A KIAA1834 | RALPSKPNSLDQFKSKLRsLsYsEILRLRQSERMSQDDFQS |
| Q96N67 | S182 | Sugiyama | DOCK7 KIAA1771 | EAPDGNSyQDDQDDLKRRsMsIDDTPRGsWACSIFDLKNSL |
| Q96PU5 | S342 | SIGNOR|ELM|iPTMNet|EPSD|PSP | NEDD4L KIAA0439 NEDL3 | NGEQFsSLIQREPssRLRsCsVtDAVAEQGHLPPPSAPAGR |
| Q96PU5 | S428 | iPTMNet|EPSD | NEDD4L KIAA0439 NEDL3 | NRTTTWTRPIMQLAEDGASGsATNSNNHLIEPQIRRPRsLs |
| Q96PU5 | S448 | GPS6|SIGNOR|ELM|EPSD|PSP | NEDD4L KIAA0439 NEDL3 | sATNSNNHLIEPQIRRPRsLssPtVTLSAPLEGAKDsPVRR |
| Q96PU5 | T367 | ELM|EPSD|PSP | NEDD4L KIAA0439 NEDL3 | VAEQGHLPPPSAPAGRARsstVtGGEEPTPsVAYVHttPGL |
| Q96PU5 | T383 | SIGNOR | NEDD4L KIAA0439 NEDL3 | ARsstVtGGEEPTPsVAYVHttPGLPSGWEERKDAKGRTYY |
| Q96QF0 | S165 | Sugiyama | RAB3IP RABIN8 | DGSDDIFGLsTDSLSRLRsPsVLEVREKGYERLKEELAKAQ |
| Q96RU3 | S497 | Sugiyama | FNBP1 FBP17 KIAA0554 | AWLAEVEGRLPARSEQARRQsGLyDSQNPPTVNNCAQDREs |
| Q96RU3 | Y500 | Sugiyama | FNBP1 FBP17 KIAA0554 | AEVEGRLPARSEQARRQsGLyDSQNPPTVNNCAQDREsPDG |
| Q96T58 | S1268 | Sugiyama | SPEN KIAA0929 MINT SHARP | SRQISEDsERtGGsPsVRHGsFHEDEDPIGsPRLLSVKGsP |
| Q99584 | S32 | Sugiyama | S100A13 | SIETVVTTFFTFARQEGRKDsLsVNEFKELVTQQLPHLLKD |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q99759 | S166 | GPS6|SIGNOR|ELM|EPSD | MAP3K3 MAPKKK3 MEKK3 | QsAGDINtIyQPPEPRsRHLsVssQNPGRssPPPGYVPERQ |
| Q99759 | S337 | GPS6|SIGNOR|ELM|EPSD | MAP3K3 MAPKKK3 MEKK3 | tNGENMGLAVQYLDPRGRLRsADsENALsVQERNVPTKsPs |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BPZ7 | S510 | Sugiyama | MAPKAP1 MIP1 SIN1 | ASTARADYFAQKQRKLNRRtsFsFQKEKKSGQQ________ |
| Q9BRF8 | T17 | Sugiyama | CPPED1 CSTP1 | ____MSAAEAGGVFHRARGRtLAAFPAEKESEWKGPFYFIL |
| Q9BUB5 | S352 | SIGNOR | MKNK1 MNK1 | KYEFPDKDWAHISSEAKDLIsKLLVRDAKQRLSAAQVLQHP |
| Q9BW19 | T157 | Sugiyama | KIFC1 HSET KNSL2 | WDLKGQLCDLNAELKRCRERtQtLDQENQQLQDQLRDAQQQ |
| Q9BXF6 | S395 | Sugiyama | RAB11FIP5 GAF1 KIAA0857 RIP11 | FsEEGPRSTDDTWPRGsRsNsssEAVLGQEELSAQAKVLAP |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9H2C0 | S272 | Sugiyama | GAN GAN1 KLHL16 | PLSQPQQGEAMLANFKPRGysECIVTVGGEERVSRKPTAAM |
| Q9H2G2 | S344 | Sugiyama | SLK KIAA0204 STK2 | EEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACILEsVS |
| Q9H3H1 | S431 | Sugiyama | TRIT1 IPT MOD5 | AAHIKSKSHLNQLKKRRRLDsDAVNTIEsQsVsPDHNKEPK |
| Q9H4A3 | T2245 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | TVNSQAAQAQPPAMTSSRKGtFtDDLHKLVDNWARDAMNLS |
| Q9H4A3 | T60 | EPSD|PSP | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GAAAADAVtGRtEEyRRRRHtMDKDSRGAAAtTtTTEHRFF |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H7D7 | S123 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | SSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLNQT |
| Q9H7E2 | S365 | Sugiyama | TDRD3 | sVLEGSGLPRNRGsERPSTssVsEVWAEDRIKCDRPYSRYD |
| Q9HA77 | S548 | Sugiyama | CARS2 OK/SW-cl.10 | TLRRGLTAHGINIKDRssttstWELLDQRTKDQKSAG____ |
| Q9NPD8 | S184 | Sugiyama | UBE2T HSPC150 PIG50 | DNLPEAGDsRVHNstQKRKAsQLVGIEKKFHPDV_______ |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQY0 | S248 | Sugiyama | BIN3 | HSDEQRERENEAKLSELRALsIVADD_______________ |
| Q9NRA8 | S353 | Sugiyama | EIF4ENIF1 | SASRFSRWFSNPsRsGsRsssLGstPHEELERLAGLEQAIL |
| Q9NUU7 | T467 | Sugiyama | DDX19A DDX19L | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9NVN8 | S513 | Sugiyama | GNL3L | PNRHQMGWAKRNVDHRPKsNsMVDVCsVDRRSVLQRIMETD |
| Q9NZN5 | T1293 | Sugiyama | ARHGEF12 KIAA0382 LARG | sVQEDWQHFPRyRtAsQGPQtDSVIQNSENIKAyHsGEGHM |
| Q9NZQ3 | T251 | Sugiyama | NCKIPSD AF3P21 SPIN90 | SPSEPGSSCSPtPPPVPRRGtHTTVsQVQPPPSKASAPEPP |
| Q9P265 | S203 | Sugiyama | DIP2B KIAA1463 | stsssASSTLSHGEVKGtsGsLADVFANtRIENFSAPPDVT |
| Q9UBP6 | S27 | Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UGV2 | S327 | Sugiyama | NDRG3 | KYFLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsV |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9ULD2 | S199 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | GKsQsFHtAGSLPPTGRRsGstsSLSySTWTSSHSDKTHAR |
| Q9ULF5 | T44 | Sugiyama | SLC39A10 KIAA1265 ZIP10 | HCHEEHDHGPEALHRQHRGMtELEPSKFSKQAAENEKKYYI |
| Q9ULL1 | S615 | Sugiyama | PLEKHG1 KIAA1209 | STETSSSGHRIVRRAssAGEsNtCPPEIGTSDRTRELQNSP |
| Q9UMR2 | T468 | Sugiyama | DDX19B DBP5 DDX19 TDBP | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9UN36 | S332 | GPS6|SIGNOR|ELM|EPSD|PSP | NDRG2 KIAA1248 SYLD | QGMGYMASSCMTRLsRsRtAsLtsAAsVDGNRsRsRtLsQs |
| Q9UN36 | S346 | EPSD|PSP | NDRG2 KIAA1248 SYLD | sRsRtAsLtsAAsVDGNRsRsRtLsQssEsGtLsSGPPGHT |
| Q9UN36 | T330 | GPS6|SIGNOR|ELM|EPSD|PSP | NDRG2 KIAA1248 SYLD | FLQGMGYMASSCMTRLsRsRtAsLtsAAsVDGNRsRsRtLs |
| Q9UN36 | T348 | GPS6|SIGNOR|ELM|EPSD|PSP | NDRG2 KIAA1248 SYLD | sRtAsLtsAAsVDGNRsRsRtLsQssEsGtLsSGPPGHTME |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UQ35 | S1539 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEs |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S992 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sssPDtKVKPEtPPRQsHsGsIsPyPKVKAQtPPGPsLsGs |
| Q9Y230 | T419 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | LRYAIQLITAASLVCRKRKGtEVQVDDIKRVysLFLDEsRS |
| Q9Y266 | T145 | Sugiyama | NUDC | AENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKLKPNLGN |
| Q9Y2B0 | S55 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDELEWEIAQVDPKKTIQMGsFRINPDGsQsVVEVPyARsE |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2I7 | S318 | EPSD|PSP | PIKFYVE KIAA0981 PIP5K3 | KsPARNRsAsItNLsLDRsGsPMVPSYEtsVsPQANRTYVR |
| Q9Y2V2 | S52 | GPS6|ELM|EPSD|PSP|Sugiyama | CARHSP1 | sPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKGVCKCFCR |
| Q9Y3S1 | T2157 | Sugiyama | WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 | GPQPALHVQAQVNNSNNKKGtFtDDLHKLVDEWTSKTVGAA |
| Q9Y534 | S58 | GPS6 | CSDC2 PIPPIN | GGVPPRDLPsPLPTKRTRTYsATARASAGPVFKGVCKQFSR |
| Q9Y6D5 | S276 | Sugiyama | ARFGEF2 ARFGEP2 BIG2 | ARSDSGKVSTENGDAPRERGssLsGtDDGAQEVVKDILEDV |
| Q9Y6D5 | S277 | Sugiyama | ARFGEF2 ARFGEP2 BIG2 | RSDSGKVSTENGDAPRERGssLsGtDDGAQEVVKDILEDVV |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.102000e-09 | 8.677 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.655269e-09 | 8.576 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.488057e-09 | 8.126 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 8.028848e-09 | 8.095 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.024482e-08 | 7.519 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.006145e-08 | 7.221 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.853861e-07 | 6.545 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.403088e-07 | 6.267 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.700452e-07 | 6.244 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.220314e-07 | 6.085 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.875002e-07 | 6.052 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.977776e-07 | 6.047 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.082451e-06 | 5.966 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.843414e-06 | 5.734 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.781909e-06 | 5.749 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.200267e-06 | 5.658 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.771050e-06 | 5.557 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.419866e-06 | 5.466 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.756969e-06 | 5.011 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.081724e-05 | 4.966 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.286055e-05 | 4.891 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.281385e-05 | 4.892 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.563269e-05 | 4.806 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.749576e-05 | 4.757 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.222941e-05 | 4.653 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.357975e-05 | 4.474 | 1 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.576080e-05 | 4.447 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.576080e-05 | 4.447 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.733869e-05 | 4.428 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.959435e-05 | 4.402 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.555474e-05 | 4.341 | 1 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.035266e-05 | 4.298 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.051993e-05 | 4.297 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.192249e-05 | 4.208 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.500799e-05 | 4.071 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.093388e-04 | 3.961 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.460858e-04 | 3.835 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.460858e-04 | 3.835 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.508439e-04 | 3.821 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.681106e-04 | 3.774 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.733722e-04 | 3.761 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.731646e-04 | 3.762 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.834945e-04 | 3.736 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.896848e-04 | 3.722 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.941905e-04 | 3.712 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.946079e-04 | 3.711 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.068654e-04 | 3.684 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.207380e-04 | 3.656 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.329909e-04 | 3.633 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.387469e-04 | 3.622 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.411689e-04 | 3.618 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.459877e-04 | 3.609 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.837096e-04 | 3.547 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.775147e-04 | 3.557 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.014909e-04 | 3.521 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.317000e-04 | 3.479 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.319569e-04 | 3.479 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.683737e-04 | 3.434 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.269550e-04 | 3.370 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.004045e-04 | 3.398 | 1 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.076421e-04 | 3.390 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.187261e-04 | 3.378 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.179898e-04 | 3.379 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.276616e-04 | 3.369 | 1 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.603901e-04 | 3.337 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.408483e-04 | 3.267 | 1 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.446659e-04 | 3.264 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.851319e-04 | 3.233 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.851319e-04 | 3.233 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.313411e-04 | 3.200 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.767366e-04 | 3.170 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.891380e-04 | 3.162 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.223680e-04 | 3.141 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.485819e-04 | 3.071 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.705711e-04 | 3.060 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.179595e-04 | 3.037 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.380133e-04 | 3.028 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.914022e-04 | 3.004 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.914621e-04 | 3.004 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.038921e-03 | 2.983 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.079482e-03 | 2.967 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.086139e-03 | 2.964 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.086139e-03 | 2.964 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.106268e-03 | 2.956 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.127042e-03 | 2.948 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.143868e-03 | 2.942 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.239321e-03 | 2.907 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.195803e-03 | 2.922 | 1 | 1 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.245119e-03 | 2.905 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.260644e-03 | 2.899 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.444997e-03 | 2.840 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.554501e-03 | 2.808 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.613314e-03 | 2.792 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.742133e-03 | 2.759 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.752504e-03 | 2.756 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.508461e-03 | 2.601 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.390007e-03 | 2.622 | 1 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.559359e-03 | 2.592 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.600529e-03 | 2.585 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.693015e-03 | 2.570 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.900047e-03 | 2.538 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.801803e-03 | 2.553 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.823263e-03 | 2.549 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.960677e-03 | 2.529 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.993069e-03 | 2.524 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.993069e-03 | 2.524 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.100085e-03 | 2.509 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.159159e-03 | 2.500 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.447940e-03 | 2.462 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.481055e-03 | 2.458 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.424637e-03 | 2.465 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.640839e-03 | 2.439 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.640839e-03 | 2.439 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.668293e-03 | 2.436 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.668293e-03 | 2.436 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.383095e-03 | 2.358 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.327816e-03 | 2.364 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.327816e-03 | 2.364 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.484539e-03 | 2.348 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.327816e-03 | 2.364 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.499519e-03 | 2.347 | 0 | 0 |
| Depurination | R-HSA-73927 | 4.520630e-03 | 2.345 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.688911e-03 | 2.329 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 4.839304e-03 | 2.315 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.872580e-03 | 2.312 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.872580e-03 | 2.312 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.299933e-03 | 2.276 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.545768e-03 | 2.256 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.385974e-03 | 2.269 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.385974e-03 | 2.269 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.640401e-03 | 2.249 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.981282e-03 | 2.223 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.877738e-03 | 2.163 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.877738e-03 | 2.163 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.879432e-03 | 2.162 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.879432e-03 | 2.162 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.885574e-03 | 2.162 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.877738e-03 | 2.163 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.885574e-03 | 2.162 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.846557e-03 | 2.165 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.885574e-03 | 2.162 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.588839e-03 | 2.181 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.990765e-03 | 2.155 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.033292e-03 | 2.153 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.070591e-03 | 2.151 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.226939e-03 | 2.141 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.257920e-03 | 2.139 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.266766e-03 | 2.139 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.425702e-03 | 2.129 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.956015e-03 | 2.099 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.561281e-03 | 2.067 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.423851e-03 | 2.074 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.131999e-03 | 2.039 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.644078e-03 | 2.016 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.847168e-03 | 2.007 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.029923e-02 | 1.987 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.047098e-02 | 1.980 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.047098e-02 | 1.980 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.085460e-02 | 1.964 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.096221e-02 | 1.960 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.172738e-02 | 1.931 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.172738e-02 | 1.931 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.120732e-02 | 1.950 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.120732e-02 | 1.950 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 1.120732e-02 | 1.950 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.120732e-02 | 1.950 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.209973e-02 | 1.917 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.151791e-02 | 1.939 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.144815e-02 | 1.941 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.263315e-02 | 1.898 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.302329e-02 | 1.885 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.308549e-02 | 1.883 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.333773e-02 | 1.875 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.347554e-02 | 1.870 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.354927e-02 | 1.868 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.361544e-02 | 1.866 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.386815e-02 | 1.858 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.386815e-02 | 1.858 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.402504e-02 | 1.853 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.446803e-02 | 1.840 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.599937e-02 | 1.796 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.599937e-02 | 1.796 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.446803e-02 | 1.840 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.514400e-02 | 1.820 | 1 | 1 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.511112e-02 | 1.821 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.582905e-02 | 1.801 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.608911e-02 | 1.793 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.849491e-02 | 1.733 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.849491e-02 | 1.733 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.647408e-02 | 1.783 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.666381e-02 | 1.778 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.666381e-02 | 1.778 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.693449e-02 | 1.771 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.680372e-02 | 1.775 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.680372e-02 | 1.775 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.802104e-02 | 1.744 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.701396e-02 | 1.769 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.837083e-02 | 1.736 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.837083e-02 | 1.736 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.666381e-02 | 1.778 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.748908e-02 | 1.757 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.774228e-02 | 1.751 | 1 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.701396e-02 | 1.769 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.774228e-02 | 1.751 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.873743e-02 | 1.727 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.892348e-02 | 1.723 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.892348e-02 | 1.723 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.987424e-02 | 1.702 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.003625e-02 | 1.698 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.046981e-02 | 1.689 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.060878e-02 | 1.686 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.119366e-02 | 1.674 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.170466e-02 | 1.663 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.170466e-02 | 1.663 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.170466e-02 | 1.663 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.267011e-02 | 1.645 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 2.267011e-02 | 1.645 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.564101e-02 | 1.591 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.564101e-02 | 1.591 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.654679e-02 | 1.576 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.530971e-02 | 1.597 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.458606e-02 | 1.609 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.323754e-02 | 1.634 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.564101e-02 | 1.591 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.574424e-02 | 1.589 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.332875e-02 | 1.632 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.501301e-02 | 1.602 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.743023e-02 | 1.562 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.979940e-02 | 1.526 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.982122e-02 | 1.525 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.014129e-02 | 1.521 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.014129e-02 | 1.521 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.014129e-02 | 1.521 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.014129e-02 | 1.521 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.014129e-02 | 1.521 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.014129e-02 | 1.521 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.014129e-02 | 1.521 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.014129e-02 | 1.521 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.014129e-02 | 1.521 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.014129e-02 | 1.521 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.014129e-02 | 1.521 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.014129e-02 | 1.521 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.085123e-02 | 1.511 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.085123e-02 | 1.511 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.156947e-02 | 1.501 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.156947e-02 | 1.501 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.164968e-02 | 1.500 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.274619e-02 | 1.485 | 1 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.278910e-02 | 1.484 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.310326e-02 | 1.480 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.332091e-02 | 1.477 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.340241e-02 | 1.476 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.340241e-02 | 1.476 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.450985e-02 | 1.462 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.466815e-02 | 1.460 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.997928e-02 | 1.398 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.932942e-02 | 1.405 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.099653e-02 | 1.387 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.099653e-02 | 1.387 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.099653e-02 | 1.387 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.580106e-02 | 1.446 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.099653e-02 | 1.387 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.798557e-02 | 1.420 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.864237e-02 | 1.413 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.588807e-02 | 1.445 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.125888e-02 | 1.384 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.155692e-02 | 1.381 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.156948e-02 | 1.381 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.182933e-02 | 1.379 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.182933e-02 | 1.379 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.203401e-02 | 1.376 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.224425e-02 | 1.374 | 1 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.224913e-02 | 1.374 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.226742e-02 | 1.374 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.226742e-02 | 1.374 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.239615e-02 | 1.373 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.239615e-02 | 1.373 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.239615e-02 | 1.373 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.373324e-02 | 1.359 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.376417e-02 | 1.359 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 4.456066e-02 | 1.351 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 4.456066e-02 | 1.351 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 4.456066e-02 | 1.351 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 4.456066e-02 | 1.351 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 4.456066e-02 | 1.351 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 4.456066e-02 | 1.351 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.222126e-02 | 1.282 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.635641e-02 | 1.334 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 4.635641e-02 | 1.334 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.635641e-02 | 1.334 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.246262e-02 | 1.280 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.246262e-02 | 1.280 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.083807e-02 | 1.294 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.576813e-02 | 1.339 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.818065e-02 | 1.317 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.948211e-02 | 1.306 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.404749e-02 | 1.356 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.635641e-02 | 1.334 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.222126e-02 | 1.282 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.116300e-02 | 1.291 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.494045e-02 | 1.347 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.660320e-02 | 1.332 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.237760e-02 | 1.281 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.718868e-02 | 1.326 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.972716e-02 | 1.303 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.635641e-02 | 1.334 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.272767e-02 | 1.278 | 1 | 1 |
| Unwinding of DNA | R-HSA-176974 | 5.246262e-02 | 1.280 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.090084e-02 | 1.293 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.741229e-02 | 1.324 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.741229e-02 | 1.324 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.293390e-02 | 1.276 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.385840e-02 | 1.269 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.416491e-02 | 1.266 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.527947e-02 | 1.257 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.669997e-02 | 1.246 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.731870e-02 | 1.242 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.739394e-02 | 1.241 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.965717e-02 | 1.224 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.134411e-02 | 1.212 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.223250e-02 | 1.206 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.286373e-02 | 1.202 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.635506e-02 | 1.178 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.636839e-02 | 1.178 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 6.778005e-02 | 1.169 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.778005e-02 | 1.169 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.834772e-02 | 1.165 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.870708e-02 | 1.163 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.870708e-02 | 1.163 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.870708e-02 | 1.163 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.870755e-02 | 1.163 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.980229e-02 | 1.156 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.105486e-02 | 1.148 | 1 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.155969e-02 | 1.145 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.246020e-02 | 1.140 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.417706e-02 | 1.130 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.767646e-02 | 1.110 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.767646e-02 | 1.110 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.866026e-02 | 1.104 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.906960e-02 | 1.102 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 8.014151e-02 | 1.096 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 8.014151e-02 | 1.096 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 8.014151e-02 | 1.096 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 8.014151e-02 | 1.096 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 8.014151e-02 | 1.096 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 9.008631e-02 | 1.045 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 9.008631e-02 | 1.045 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.804094e-02 | 1.055 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.804094e-02 | 1.055 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.364368e-02 | 1.029 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.364368e-02 | 1.029 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.154408e-02 | 1.038 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.299594e-02 | 1.081 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 9.064617e-02 | 1.043 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.195852e-02 | 1.086 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.992107e-02 | 1.046 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.536484e-02 | 1.021 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.423576e-02 | 1.075 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 9.364368e-02 | 1.029 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.006030e-01 | 0.997 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.006030e-01 | 0.997 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.275245e-02 | 1.033 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.004771e-01 | 0.998 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.622445e-02 | 1.017 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.367701e-02 | 1.077 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.367701e-02 | 1.077 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.123291e-02 | 1.090 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.359874e-02 | 1.078 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.359874e-02 | 1.078 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 8.804094e-02 | 1.055 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.616081e-02 | 1.065 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.771097e-02 | 1.010 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.822270e-02 | 1.008 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.364368e-02 | 1.029 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.012817e-01 | 0.994 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.012817e-01 | 0.994 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.051071e-01 | 0.978 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.059181e-01 | 0.975 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.085005e-01 | 0.965 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.085005e-01 | 0.965 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.109515e-01 | 0.955 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.112066e-01 | 0.954 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.131586e-01 | 0.946 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.131586e-01 | 0.946 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.131586e-01 | 0.946 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.131586e-01 | 0.946 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.131874e-01 | 0.946 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.134142e-01 | 0.945 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.138521e-01 | 0.944 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.138521e-01 | 0.944 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.138521e-01 | 0.944 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.162478e-01 | 0.935 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.203045e-01 | 0.920 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.207618e-01 | 0.918 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.207618e-01 | 0.918 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.219751e-01 | 0.914 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.219751e-01 | 0.914 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.219751e-01 | 0.914 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.224015e-01 | 0.912 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.228232e-01 | 0.911 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.231576e-01 | 0.910 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.253038e-01 | 0.902 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.269057e-01 | 0.897 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.276910e-01 | 0.894 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.305016e-01 | 0.884 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.310706e-01 | 0.882 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.314682e-01 | 0.881 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.318080e-01 | 0.880 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.318080e-01 | 0.880 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.318080e-01 | 0.880 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.318080e-01 | 0.880 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.318080e-01 | 0.880 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.318080e-01 | 0.880 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.318080e-01 | 0.880 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.331505e-01 | 0.876 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.346295e-01 | 0.871 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.351493e-01 | 0.869 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.366915e-01 | 0.864 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.366915e-01 | 0.864 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.534263e-01 | 0.814 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.534263e-01 | 0.814 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.534263e-01 | 0.814 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.534263e-01 | 0.814 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.441348e-01 | 0.841 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.441348e-01 | 0.841 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.441348e-01 | 0.841 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.441348e-01 | 0.841 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.441348e-01 | 0.841 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.441348e-01 | 0.841 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.503792e-01 | 0.823 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.503792e-01 | 0.823 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.503792e-01 | 0.823 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.503792e-01 | 0.823 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.503792e-01 | 0.823 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.425628e-01 | 0.846 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.425628e-01 | 0.846 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.425628e-01 | 0.846 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.419411e-01 | 0.848 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.419411e-01 | 0.848 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.419411e-01 | 0.848 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.521082e-01 | 0.818 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.697530e-01 | 0.770 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.671130e-01 | 0.777 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.633447e-01 | 0.787 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.836524e-01 | 0.736 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.412584e-01 | 0.850 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.702287e-01 | 0.769 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.650318e-01 | 0.782 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.737805e-01 | 0.760 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.476872e-01 | 0.831 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.571490e-01 | 0.804 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.737805e-01 | 0.760 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.646952e-01 | 0.783 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.529340e-01 | 0.815 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.529340e-01 | 0.815 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.529340e-01 | 0.815 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.425628e-01 | 0.846 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.671130e-01 | 0.777 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.703142e-01 | 0.769 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.836524e-01 | 0.736 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.787586e-01 | 0.748 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.425628e-01 | 0.846 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.693822e-01 | 0.771 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.599218e-01 | 0.796 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.755246e-01 | 0.756 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.676674e-01 | 0.776 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.728869e-01 | 0.762 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.425628e-01 | 0.846 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.460772e-01 | 0.835 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.842984e-01 | 0.734 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.877861e-01 | 0.726 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.877861e-01 | 0.726 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 1.881235e-01 | 0.726 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.882995e-01 | 0.725 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.882995e-01 | 0.725 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.888778e-01 | 0.724 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.888778e-01 | 0.724 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.888778e-01 | 0.724 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.888778e-01 | 0.724 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.888778e-01 | 0.724 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.891539e-01 | 0.723 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.898608e-01 | 0.722 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.902905e-01 | 0.721 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.908608e-01 | 0.719 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.908608e-01 | 0.719 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.833203e-01 | 0.548 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.833203e-01 | 0.548 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 2.833203e-01 | 0.548 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.833203e-01 | 0.548 | 0 | 0 |
| Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-9036092 | 2.833203e-01 | 0.548 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.833203e-01 | 0.548 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.833203e-01 | 0.548 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.833203e-01 | 0.548 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.833203e-01 | 0.548 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.833203e-01 | 0.548 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.833203e-01 | 0.548 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.030211e-01 | 0.692 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 2.030211e-01 | 0.692 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.030211e-01 | 0.692 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.030211e-01 | 0.692 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.639898e-01 | 0.578 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.639898e-01 | 0.578 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.639898e-01 | 0.578 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.639898e-01 | 0.578 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.639898e-01 | 0.578 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.639898e-01 | 0.578 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.639898e-01 | 0.578 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.639898e-01 | 0.578 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.932904e-01 | 0.405 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.932904e-01 | 0.405 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.932904e-01 | 0.405 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.932904e-01 | 0.405 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.932904e-01 | 0.405 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.932904e-01 | 0.405 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.932904e-01 | 0.405 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.932904e-01 | 0.405 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.932904e-01 | 0.405 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.932904e-01 | 0.405 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.932904e-01 | 0.405 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.932904e-01 | 0.405 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.932904e-01 | 0.405 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.932904e-01 | 0.405 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.932904e-01 | 0.405 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.932904e-01 | 0.405 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.932904e-01 | 0.405 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.932904e-01 | 0.405 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.932904e-01 | 0.405 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.932904e-01 | 0.405 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.932904e-01 | 0.405 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.932904e-01 | 0.405 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.932904e-01 | 0.405 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.932904e-01 | 0.405 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.336786e-01 | 0.631 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.336786e-01 | 0.631 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.336786e-01 | 0.631 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 2.336786e-01 | 0.631 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.336786e-01 | 0.631 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.336786e-01 | 0.631 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.070768e-01 | 0.684 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.070768e-01 | 0.684 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.070768e-01 | 0.684 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.070768e-01 | 0.684 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.070768e-01 | 0.684 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.070768e-01 | 0.684 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 3.250166e-01 | 0.488 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.250166e-01 | 0.488 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.250166e-01 | 0.488 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.250166e-01 | 0.488 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 3.250166e-01 | 0.488 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.779687e-01 | 0.556 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.420089e-01 | 0.616 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.143258e-01 | 0.669 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.430118e-01 | 0.614 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.430118e-01 | 0.614 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.781365e-01 | 0.556 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.229536e-01 | 0.491 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.229536e-01 | 0.491 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.229536e-01 | 0.491 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.846489e-01 | 0.415 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.846489e-01 | 0.415 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.846489e-01 | 0.415 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.846489e-01 | 0.415 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.863915e-01 | 0.313 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 4.863915e-01 | 0.313 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.863915e-01 | 0.313 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.863915e-01 | 0.313 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.863915e-01 | 0.313 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.863915e-01 | 0.313 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.863915e-01 | 0.313 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.863915e-01 | 0.313 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.863915e-01 | 0.313 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.863915e-01 | 0.313 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.408637e-01 | 0.618 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.408637e-01 | 0.618 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.408637e-01 | 0.618 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.408637e-01 | 0.618 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.408637e-01 | 0.618 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.408637e-01 | 0.618 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.740418e-01 | 0.562 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.740418e-01 | 0.562 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.150356e-01 | 0.502 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.150356e-01 | 0.502 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.150356e-01 | 0.502 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.150356e-01 | 0.502 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.076830e-01 | 0.683 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.076830e-01 | 0.683 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.076830e-01 | 0.683 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.683081e-01 | 0.571 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.679552e-01 | 0.434 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.679552e-01 | 0.434 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.679552e-01 | 0.434 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.679552e-01 | 0.434 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.679552e-01 | 0.434 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.679552e-01 | 0.434 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.327084e-01 | 0.633 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.327084e-01 | 0.633 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.327084e-01 | 0.633 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.058278e-01 | 0.515 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.058278e-01 | 0.515 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.001301e-01 | 0.699 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.964724e-01 | 0.528 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.418783e-01 | 0.355 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 4.418783e-01 | 0.355 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.418783e-01 | 0.355 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.421289e-01 | 0.616 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.421289e-01 | 0.616 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.123981e-01 | 0.385 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.123981e-01 | 0.385 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.620671e-01 | 0.582 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.620671e-01 | 0.582 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.620671e-01 | 0.582 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.132926e-01 | 0.504 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.132926e-01 | 0.504 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.132926e-01 | 0.504 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.895916e-01 | 0.409 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.895916e-01 | 0.409 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.920811e-01 | 0.534 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.332774e-01 | 0.632 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.332774e-01 | 0.632 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.706288e-01 | 0.431 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.542178e-01 | 0.451 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.396532e-01 | 0.469 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.396532e-01 | 0.469 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.396532e-01 | 0.469 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.396532e-01 | 0.469 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.396532e-01 | 0.469 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.033917e-01 | 0.518 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.946573e-01 | 0.711 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.246349e-01 | 0.489 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.510177e-01 | 0.455 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.834394e-01 | 0.416 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.834394e-01 | 0.416 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.265578e-01 | 0.370 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.265578e-01 | 0.370 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.558083e-01 | 0.341 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.558083e-01 | 0.341 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.558083e-01 | 0.341 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 4.960384e-01 | 0.304 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.960384e-01 | 0.304 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.960384e-01 | 0.304 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.960384e-01 | 0.304 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.960384e-01 | 0.304 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.960384e-01 | 0.304 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.960384e-01 | 0.304 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.960384e-01 | 0.304 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.652106e-01 | 0.248 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 5.652106e-01 | 0.248 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.652106e-01 | 0.248 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.652106e-01 | 0.248 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 5.652106e-01 | 0.248 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.652106e-01 | 0.248 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.757423e-01 | 0.425 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.757423e-01 | 0.425 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.068030e-01 | 0.513 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.930381e-01 | 0.406 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.930381e-01 | 0.406 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.930381e-01 | 0.406 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.126671e-01 | 0.384 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.126671e-01 | 0.384 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.354776e-01 | 0.361 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.354776e-01 | 0.361 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.354776e-01 | 0.361 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.834211e-01 | 0.416 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.005727e-01 | 0.397 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 4.629214e-01 | 0.334 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.198022e-01 | 0.377 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.198022e-01 | 0.377 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.198022e-01 | 0.377 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.978066e-01 | 0.303 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.978066e-01 | 0.303 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.978066e-01 | 0.303 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.978066e-01 | 0.303 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.978066e-01 | 0.303 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.893258e-01 | 0.410 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.161039e-01 | 0.381 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 4.501513e-01 | 0.347 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.984370e-01 | 0.302 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.984370e-01 | 0.302 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.467236e-01 | 0.262 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 5.467236e-01 | 0.262 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 5.467236e-01 | 0.262 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 5.467236e-01 | 0.262 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.467236e-01 | 0.262 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 5.467236e-01 | 0.262 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.467236e-01 | 0.262 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 5.467236e-01 | 0.262 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.467236e-01 | 0.262 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.467236e-01 | 0.262 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.369724e-01 | 0.360 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.712893e-01 | 0.430 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.728716e-01 | 0.325 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.728716e-01 | 0.325 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.987267e-01 | 0.302 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.987267e-01 | 0.302 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.187735e-01 | 0.378 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.747123e-01 | 0.324 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.120983e-01 | 0.385 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.120983e-01 | 0.385 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.577876e-01 | 0.339 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.988774e-01 | 0.302 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.988774e-01 | 0.302 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.381007e-01 | 0.269 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.328992e-01 | 0.273 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.328992e-01 | 0.273 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.328992e-01 | 0.273 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.990410e-01 | 0.302 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.990410e-01 | 0.302 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.266842e-01 | 0.278 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.266842e-01 | 0.278 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.266842e-01 | 0.278 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.246214e-01 | 0.280 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.147925e-01 | 0.288 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.538410e-01 | 0.257 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.590704e-01 | 0.253 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.661413e-01 | 0.247 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.743302e-01 | 0.241 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.677586e-01 | 0.572 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.443269e-01 | 0.352 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.443269e-01 | 0.352 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.743302e-01 | 0.241 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.952418e-01 | 0.403 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.655423e-01 | 0.248 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.926273e-01 | 0.406 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.735158e-01 | 0.563 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.031579e-01 | 0.395 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.366398e-01 | 0.270 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.040419e-01 | 0.690 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.265578e-01 | 0.370 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.031579e-01 | 0.395 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.756253e-01 | 0.425 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.669895e-01 | 0.435 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.988774e-01 | 0.302 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.209640e-01 | 0.376 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 3.229536e-01 | 0.491 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 4.629214e-01 | 0.334 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.329631e-01 | 0.478 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.998879e-01 | 0.523 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.998879e-01 | 0.523 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.128629e-01 | 0.290 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.040132e-01 | 0.394 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.930824e-01 | 0.533 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.229535e-01 | 0.282 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.800624e-01 | 0.420 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.250166e-01 | 0.488 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.873343e-01 | 0.542 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.701144e-01 | 0.568 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.987267e-01 | 0.302 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.808832e-01 | 0.318 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.895916e-01 | 0.409 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.510177e-01 | 0.455 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.832990e-01 | 0.416 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.229536e-01 | 0.491 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.679552e-01 | 0.434 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.265035e-01 | 0.486 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.834394e-01 | 0.416 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.777588e-01 | 0.556 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.711058e-01 | 0.431 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.381007e-01 | 0.269 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.394575e-01 | 0.268 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.629214e-01 | 0.334 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.639898e-01 | 0.578 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.679552e-01 | 0.434 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.372322e-01 | 0.472 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.960384e-01 | 0.304 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.960384e-01 | 0.304 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.757423e-01 | 0.425 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.728716e-01 | 0.325 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.246349e-01 | 0.489 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.746086e-01 | 0.426 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.906909e-01 | 0.537 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.553014e-01 | 0.593 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.486698e-01 | 0.604 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.381071e-01 | 0.471 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.336786e-01 | 0.631 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.143258e-01 | 0.669 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.774439e-01 | 0.321 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.746086e-01 | 0.426 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.158412e-01 | 0.381 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.777588e-01 | 0.556 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.250166e-01 | 0.488 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.229536e-01 | 0.491 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.229536e-01 | 0.491 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 3.523087e-01 | 0.453 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.023069e-01 | 0.520 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.542178e-01 | 0.451 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.558083e-01 | 0.341 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.978066e-01 | 0.303 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.467236e-01 | 0.262 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.467236e-01 | 0.262 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.158412e-01 | 0.381 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.661413e-01 | 0.247 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.359702e-01 | 0.271 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.417438e-01 | 0.355 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.993434e-01 | 0.700 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.278321e-01 | 0.642 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.964724e-01 | 0.528 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.033917e-01 | 0.518 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.978066e-01 | 0.303 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.386509e-01 | 0.622 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.442609e-01 | 0.463 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.987841e-01 | 0.302 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.105655e-01 | 0.508 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.984370e-01 | 0.302 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.397512e-01 | 0.357 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.336563e-01 | 0.631 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.414475e-01 | 0.266 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.340584e-01 | 0.476 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.357337e-01 | 0.628 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.705245e-01 | 0.327 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.430118e-01 | 0.614 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.930381e-01 | 0.406 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.336563e-01 | 0.631 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.989117e-01 | 0.701 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.489602e-01 | 0.260 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.218829e-01 | 0.375 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.130072e-01 | 0.672 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.846489e-01 | 0.415 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 3.523087e-01 | 0.453 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 4.418783e-01 | 0.355 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.558083e-01 | 0.341 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.757423e-01 | 0.425 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.898125e-01 | 0.409 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.984370e-01 | 0.302 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 5.467236e-01 | 0.262 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 5.467236e-01 | 0.262 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 5.467236e-01 | 0.262 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.728716e-01 | 0.325 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.989601e-01 | 0.302 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.215677e-01 | 0.283 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.314459e-01 | 0.275 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.987654e-01 | 0.302 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.423124e-01 | 0.354 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.237118e-01 | 0.490 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.965495e-01 | 0.402 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.561421e-01 | 0.448 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.328992e-01 | 0.273 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.327084e-01 | 0.633 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.716554e-01 | 0.326 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.076830e-01 | 0.683 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.629214e-01 | 0.334 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.736790e-01 | 0.325 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.662793e-01 | 0.436 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.978066e-01 | 0.303 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.743894e-01 | 0.562 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.639898e-01 | 0.578 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.895916e-01 | 0.409 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.467236e-01 | 0.262 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.728716e-01 | 0.325 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.381007e-01 | 0.269 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.972574e-01 | 0.303 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.005727e-01 | 0.397 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.076830e-01 | 0.683 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.033917e-01 | 0.518 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.272290e-01 | 0.644 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.430118e-01 | 0.614 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.619172e-01 | 0.582 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.279544e-01 | 0.484 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.893735e-01 | 0.410 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.420089e-01 | 0.616 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.679552e-01 | 0.434 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 4.418783e-01 | 0.355 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.464835e-01 | 0.262 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.960688e-01 | 0.708 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.497700e-01 | 0.260 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.834211e-01 | 0.416 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.510177e-01 | 0.455 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.697890e-01 | 0.569 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.833203e-01 | 0.548 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.420089e-01 | 0.616 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.420089e-01 | 0.616 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.430118e-01 | 0.614 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.846489e-01 | 0.415 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.863915e-01 | 0.313 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.863915e-01 | 0.313 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.964724e-01 | 0.528 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.123981e-01 | 0.385 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.123981e-01 | 0.385 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.234770e-01 | 0.651 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 4.265578e-01 | 0.370 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.652106e-01 | 0.248 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.898479e-01 | 0.538 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.354776e-01 | 0.361 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.629214e-01 | 0.334 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.417438e-01 | 0.355 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.978066e-01 | 0.303 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 3.625601e-01 | 0.441 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.743302e-01 | 0.241 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.005727e-01 | 0.397 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.394575e-01 | 0.268 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.781365e-01 | 0.556 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.706288e-01 | 0.431 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.743302e-01 | 0.241 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.462414e-01 | 0.350 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.229536e-01 | 0.491 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.126671e-01 | 0.384 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.176328e-01 | 0.662 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.265035e-01 | 0.486 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.743302e-01 | 0.241 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 3.250166e-01 | 0.488 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.846489e-01 | 0.415 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.418783e-01 | 0.355 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.960384e-01 | 0.304 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.978066e-01 | 0.303 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.978066e-01 | 0.303 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.978066e-01 | 0.303 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.984370e-01 | 0.302 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.381007e-01 | 0.269 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.989601e-01 | 0.302 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.464835e-01 | 0.262 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.781469e-01 | 0.320 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.336786e-01 | 0.631 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.022333e-01 | 0.520 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.381007e-01 | 0.269 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.170029e-01 | 0.287 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.437019e-01 | 0.464 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.356585e-01 | 0.628 | 1 | 1 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.661413e-01 | 0.247 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.932904e-01 | 0.405 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.863915e-01 | 0.313 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.150356e-01 | 0.502 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.679552e-01 | 0.434 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.123981e-01 | 0.385 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.542178e-01 | 0.451 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.652106e-01 | 0.248 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.652106e-01 | 0.248 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.990058e-01 | 0.302 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.437572e-01 | 0.265 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.590704e-01 | 0.253 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.475342e-01 | 0.459 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.437572e-01 | 0.265 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.143258e-01 | 0.669 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.295122e-01 | 0.639 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.288568e-01 | 0.277 | 1 | 1 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.683081e-01 | 0.571 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.123981e-01 | 0.385 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.706288e-01 | 0.431 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.652106e-01 | 0.248 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.246214e-01 | 0.280 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.779687e-01 | 0.556 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.863915e-01 | 0.313 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 4.960384e-01 | 0.304 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.652106e-01 | 0.248 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 5.467236e-01 | 0.262 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.661413e-01 | 0.247 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.619172e-01 | 0.582 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.130072e-01 | 0.672 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 4.418783e-01 | 0.355 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.960384e-01 | 0.304 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 5.652106e-01 | 0.248 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 5.328992e-01 | 0.273 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.157972e-01 | 0.288 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.458417e-01 | 0.263 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.562450e-01 | 0.591 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.764758e-01 | 0.239 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.764758e-01 | 0.239 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.764758e-01 | 0.239 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.769054e-01 | 0.239 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.802574e-01 | 0.236 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.802574e-01 | 0.236 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.824777e-01 | 0.235 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.839761e-01 | 0.234 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.878405e-01 | 0.231 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.917563e-01 | 0.228 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.937251e-01 | 0.226 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.937251e-01 | 0.226 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 5.937251e-01 | 0.226 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.937251e-01 | 0.226 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.937251e-01 | 0.226 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.937251e-01 | 0.226 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.943555e-01 | 0.226 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.977451e-01 | 0.223 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.977451e-01 | 0.223 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.980321e-01 | 0.223 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.980321e-01 | 0.223 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.980321e-01 | 0.223 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.982360e-01 | 0.223 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.982360e-01 | 0.223 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.038150e-01 | 0.219 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.065610e-01 | 0.217 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.077034e-01 | 0.216 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.077034e-01 | 0.216 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.127653e-01 | 0.213 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.127842e-01 | 0.213 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.127842e-01 | 0.213 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.127842e-01 | 0.213 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.127842e-01 | 0.213 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.127842e-01 | 0.213 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.127842e-01 | 0.213 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.127842e-01 | 0.213 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.127842e-01 | 0.213 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.139582e-01 | 0.212 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.155519e-01 | 0.211 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.155519e-01 | 0.211 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.155519e-01 | 0.211 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.155519e-01 | 0.211 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.155519e-01 | 0.211 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.164025e-01 | 0.210 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.180526e-01 | 0.209 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.180526e-01 | 0.209 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.214308e-01 | 0.207 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.214308e-01 | 0.207 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.236678e-01 | 0.205 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.244696e-01 | 0.204 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.279950e-01 | 0.202 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.284735e-01 | 0.202 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.305774e-01 | 0.200 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 6.319377e-01 | 0.199 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 6.319377e-01 | 0.199 | 0 | 0 |
| Defective MAT1A causes MATD | R-HSA-5579024 | 6.319377e-01 | 0.199 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 6.319377e-01 | 0.199 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.319377e-01 | 0.199 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 6.319377e-01 | 0.199 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.319377e-01 | 0.199 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.319377e-01 | 0.199 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 6.319377e-01 | 0.199 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.319377e-01 | 0.199 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 6.319377e-01 | 0.199 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 6.319377e-01 | 0.199 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.369797e-01 | 0.196 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 6.369797e-01 | 0.196 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.369797e-01 | 0.196 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 6.369797e-01 | 0.196 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.369797e-01 | 0.196 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 6.369797e-01 | 0.196 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.399866e-01 | 0.194 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.407172e-01 | 0.193 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.421357e-01 | 0.192 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.421357e-01 | 0.192 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.421357e-01 | 0.192 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.438675e-01 | 0.191 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.438675e-01 | 0.191 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.464247e-01 | 0.189 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.469364e-01 | 0.189 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.469364e-01 | 0.189 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.469364e-01 | 0.189 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.473992e-01 | 0.189 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.523793e-01 | 0.185 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.523793e-01 | 0.185 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.536376e-01 | 0.185 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.543674e-01 | 0.184 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.558591e-01 | 0.183 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.573973e-01 | 0.182 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.591181e-01 | 0.181 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.655078e-01 | 0.177 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.655078e-01 | 0.177 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.655078e-01 | 0.177 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.655078e-01 | 0.177 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.668302e-01 | 0.176 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.668302e-01 | 0.176 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.675411e-01 | 0.176 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.675411e-01 | 0.176 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.696507e-01 | 0.174 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.723705e-01 | 0.172 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.757753e-01 | 0.170 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.765305e-01 | 0.170 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 6.765305e-01 | 0.170 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.765305e-01 | 0.170 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 6.765305e-01 | 0.170 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.765305e-01 | 0.170 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.769709e-01 | 0.169 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.771887e-01 | 0.169 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.771887e-01 | 0.169 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.771887e-01 | 0.169 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.788913e-01 | 0.168 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.788913e-01 | 0.168 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.788913e-01 | 0.168 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.788913e-01 | 0.168 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.788913e-01 | 0.168 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.788913e-01 | 0.168 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.794527e-01 | 0.168 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.847615e-01 | 0.164 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.847615e-01 | 0.164 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.863220e-01 | 0.163 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.884275e-01 | 0.162 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.884275e-01 | 0.162 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.884275e-01 | 0.162 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.884275e-01 | 0.162 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.884275e-01 | 0.162 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.884275e-01 | 0.162 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.884275e-01 | 0.162 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.884275e-01 | 0.162 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.884275e-01 | 0.162 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.884275e-01 | 0.162 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.884275e-01 | 0.162 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.884275e-01 | 0.162 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.884275e-01 | 0.162 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 6.884275e-01 | 0.162 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.884275e-01 | 0.162 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.886309e-01 | 0.162 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.899161e-01 | 0.161 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.914770e-01 | 0.160 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.917338e-01 | 0.160 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 6.917338e-01 | 0.160 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.917338e-01 | 0.160 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.942566e-01 | 0.158 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.942566e-01 | 0.158 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.942566e-01 | 0.158 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.942566e-01 | 0.158 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.942566e-01 | 0.158 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.036154e-01 | 0.153 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.036154e-01 | 0.153 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.052180e-01 | 0.152 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.062880e-01 | 0.151 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.062880e-01 | 0.151 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.062880e-01 | 0.151 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.062880e-01 | 0.151 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.062880e-01 | 0.151 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.062880e-01 | 0.151 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.062880e-01 | 0.151 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.086476e-01 | 0.150 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.086476e-01 | 0.150 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.086476e-01 | 0.150 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.086476e-01 | 0.150 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.086476e-01 | 0.150 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.089369e-01 | 0.149 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 7.105473e-01 | 0.148 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.105473e-01 | 0.148 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.105473e-01 | 0.148 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.106130e-01 | 0.148 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.106130e-01 | 0.148 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.115071e-01 | 0.148 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.124953e-01 | 0.147 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.124953e-01 | 0.147 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.124953e-01 | 0.147 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.124953e-01 | 0.147 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.124953e-01 | 0.147 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.124953e-01 | 0.147 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.134218e-01 | 0.147 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.146939e-01 | 0.146 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.146939e-01 | 0.146 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.146939e-01 | 0.146 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.146939e-01 | 0.146 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.183804e-01 | 0.144 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.198256e-01 | 0.143 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.205354e-01 | 0.142 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.254625e-01 | 0.139 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.294094e-01 | 0.137 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.311225e-01 | 0.136 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.347560e-01 | 0.134 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.347560e-01 | 0.134 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.347560e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.362365e-01 | 0.133 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 7.362500e-01 | 0.133 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 7.362500e-01 | 0.133 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 7.362500e-01 | 0.133 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 7.362500e-01 | 0.133 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 7.362500e-01 | 0.133 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 7.362500e-01 | 0.133 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 7.362500e-01 | 0.133 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 7.362500e-01 | 0.133 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 7.362500e-01 | 0.133 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 7.362500e-01 | 0.133 | 0 | 0 |
| Terminal pathway of complement | R-HSA-166665 | 7.362500e-01 | 0.133 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.362500e-01 | 0.133 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 7.362500e-01 | 0.133 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 7.362500e-01 | 0.133 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 7.362500e-01 | 0.133 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 7.362500e-01 | 0.133 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 7.362500e-01 | 0.133 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.362500e-01 | 0.133 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 7.362500e-01 | 0.133 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 7.362500e-01 | 0.133 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 7.362500e-01 | 0.133 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 7.362500e-01 | 0.133 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.364150e-01 | 0.133 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.364150e-01 | 0.133 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.364150e-01 | 0.133 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.368767e-01 | 0.133 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.380001e-01 | 0.132 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.425768e-01 | 0.129 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.425768e-01 | 0.129 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.435495e-01 | 0.129 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.436251e-01 | 0.129 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.450431e-01 | 0.128 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.450431e-01 | 0.128 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.450431e-01 | 0.128 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.450431e-01 | 0.128 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.450431e-01 | 0.128 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.450431e-01 | 0.128 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.450431e-01 | 0.128 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.450431e-01 | 0.128 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 7.450431e-01 | 0.128 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.450431e-01 | 0.128 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.450431e-01 | 0.128 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.450431e-01 | 0.128 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.456968e-01 | 0.127 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.456968e-01 | 0.127 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.481795e-01 | 0.126 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.488592e-01 | 0.126 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.527231e-01 | 0.123 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.558884e-01 | 0.122 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.569021e-01 | 0.121 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.569021e-01 | 0.121 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.573210e-01 | 0.121 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.573210e-01 | 0.121 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.574053e-01 | 0.121 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.574778e-01 | 0.121 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.617146e-01 | 0.118 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.617146e-01 | 0.118 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.617146e-01 | 0.118 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.617146e-01 | 0.118 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.622532e-01 | 0.118 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.627648e-01 | 0.118 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.692871e-01 | 0.114 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 7.743755e-01 | 0.111 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.743755e-01 | 0.111 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.743755e-01 | 0.111 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 7.743755e-01 | 0.111 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.743755e-01 | 0.111 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.743755e-01 | 0.111 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.767347e-01 | 0.110 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.767347e-01 | 0.110 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.767347e-01 | 0.110 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 7.767347e-01 | 0.110 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.767347e-01 | 0.110 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.767347e-01 | 0.110 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.767347e-01 | 0.110 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.767347e-01 | 0.110 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.767347e-01 | 0.110 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 7.767347e-01 | 0.110 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 7.767347e-01 | 0.110 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.767347e-01 | 0.110 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.767347e-01 | 0.110 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.774814e-01 | 0.109 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.774814e-01 | 0.109 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.780544e-01 | 0.109 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.785216e-01 | 0.109 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.785273e-01 | 0.109 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.785273e-01 | 0.109 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.785273e-01 | 0.109 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.851579e-01 | 0.105 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.851579e-01 | 0.105 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.851579e-01 | 0.105 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.874648e-01 | 0.104 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.874854e-01 | 0.104 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.918037e-01 | 0.101 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.921630e-01 | 0.101 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.928969e-01 | 0.101 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.928969e-01 | 0.101 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.931174e-01 | 0.101 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.931174e-01 | 0.101 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.938682e-01 | 0.100 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.943379e-01 | 0.100 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.968807e-01 | 0.099 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.981653e-01 | 0.098 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.981653e-01 | 0.098 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.981653e-01 | 0.098 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.007125e-01 | 0.097 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.007125e-01 | 0.097 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.007125e-01 | 0.097 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.007125e-01 | 0.097 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.007125e-01 | 0.097 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.007125e-01 | 0.097 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.066568e-01 | 0.093 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.066568e-01 | 0.093 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.066568e-01 | 0.093 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.066568e-01 | 0.093 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.066568e-01 | 0.093 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.079086e-01 | 0.093 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.079086e-01 | 0.093 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.099895e-01 | 0.092 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.108356e-01 | 0.091 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 8.110070e-01 | 0.091 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 8.110070e-01 | 0.091 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 8.110070e-01 | 0.091 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 8.110070e-01 | 0.091 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 8.110070e-01 | 0.091 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 8.110070e-01 | 0.091 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 8.110070e-01 | 0.091 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 8.110070e-01 | 0.091 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 8.110070e-01 | 0.091 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 8.110070e-01 | 0.091 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 8.110070e-01 | 0.091 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 8.110070e-01 | 0.091 | 0 | 0 |
| Biosynthesis of maresin conjugates in tissue regeneration (MCTR) | R-HSA-9026762 | 8.110070e-01 | 0.091 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 8.110070e-01 | 0.091 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.110257e-01 | 0.091 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.111502e-01 | 0.091 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.111502e-01 | 0.091 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.163714e-01 | 0.088 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.163714e-01 | 0.088 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.193252e-01 | 0.087 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.214647e-01 | 0.085 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.218721e-01 | 0.085 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.218968e-01 | 0.085 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.234934e-01 | 0.084 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.234934e-01 | 0.084 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.236134e-01 | 0.084 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.238705e-01 | 0.084 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.242825e-01 | 0.084 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.242825e-01 | 0.084 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.242825e-01 | 0.084 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.242825e-01 | 0.084 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.242825e-01 | 0.084 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.242825e-01 | 0.084 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.242825e-01 | 0.084 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.242825e-01 | 0.084 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.243773e-01 | 0.084 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.263119e-01 | 0.083 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.263119e-01 | 0.083 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.263119e-01 | 0.083 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.263119e-01 | 0.083 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.263119e-01 | 0.083 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.266376e-01 | 0.083 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.325700e-01 | 0.080 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.332048e-01 | 0.079 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.332048e-01 | 0.079 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.332048e-01 | 0.079 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.339498e-01 | 0.079 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.342422e-01 | 0.079 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.350285e-01 | 0.078 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.373863e-01 | 0.077 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 8.400201e-01 | 0.076 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 8.400201e-01 | 0.076 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 8.400201e-01 | 0.076 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 8.400201e-01 | 0.076 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 8.400201e-01 | 0.076 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 8.400201e-01 | 0.076 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 8.400201e-01 | 0.076 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 8.400201e-01 | 0.076 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 8.400201e-01 | 0.076 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 8.400201e-01 | 0.076 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 8.400201e-01 | 0.076 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.400201e-01 | 0.076 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 8.400201e-01 | 0.076 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 8.400201e-01 | 0.076 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 8.400201e-01 | 0.076 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.416205e-01 | 0.075 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.442297e-01 | 0.074 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.442297e-01 | 0.074 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.442297e-01 | 0.074 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.442297e-01 | 0.074 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.442297e-01 | 0.074 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.442297e-01 | 0.074 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.442297e-01 | 0.074 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.449947e-01 | 0.073 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.450217e-01 | 0.073 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.453142e-01 | 0.073 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.453142e-01 | 0.073 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 8.453142e-01 | 0.073 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.453142e-01 | 0.073 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 8.453142e-01 | 0.073 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.487297e-01 | 0.071 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.497549e-01 | 0.071 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.504948e-01 | 0.070 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.522216e-01 | 0.069 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.546688e-01 | 0.068 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.581243e-01 | 0.066 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.605207e-01 | 0.065 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.605207e-01 | 0.065 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.605207e-01 | 0.065 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.625175e-01 | 0.064 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.625175e-01 | 0.064 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.625175e-01 | 0.064 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.630134e-01 | 0.064 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.630134e-01 | 0.064 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.640313e-01 | 0.063 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.640313e-01 | 0.063 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.640313e-01 | 0.063 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.640313e-01 | 0.063 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.645613e-01 | 0.063 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.645806e-01 | 0.063 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.645806e-01 | 0.063 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.645806e-01 | 0.063 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 8.645806e-01 | 0.063 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.645806e-01 | 0.063 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.645806e-01 | 0.063 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.645806e-01 | 0.063 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.645806e-01 | 0.063 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.645806e-01 | 0.063 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.645806e-01 | 0.063 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.645806e-01 | 0.063 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.659439e-01 | 0.063 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.710023e-01 | 0.060 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.733730e-01 | 0.059 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.738253e-01 | 0.059 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.751915e-01 | 0.058 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.752957e-01 | 0.058 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.752957e-01 | 0.058 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.764885e-01 | 0.057 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.771409e-01 | 0.057 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.800787e-01 | 0.055 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.806488e-01 | 0.055 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.806488e-01 | 0.055 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.843437e-01 | 0.053 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.843437e-01 | 0.053 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.844956e-01 | 0.053 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.853718e-01 | 0.053 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.853718e-01 | 0.053 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.853718e-01 | 0.053 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.853718e-01 | 0.053 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.853718e-01 | 0.053 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.853718e-01 | 0.053 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.853718e-01 | 0.053 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.853718e-01 | 0.053 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.853718e-01 | 0.053 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.853718e-01 | 0.053 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.853718e-01 | 0.053 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.853718e-01 | 0.053 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.863616e-01 | 0.052 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.881366e-01 | 0.052 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.886650e-01 | 0.051 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.886650e-01 | 0.051 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.886650e-01 | 0.051 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.886650e-01 | 0.051 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.886650e-01 | 0.051 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.886650e-01 | 0.051 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.886650e-01 | 0.051 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.886650e-01 | 0.051 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.886650e-01 | 0.051 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.904350e-01 | 0.050 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.904350e-01 | 0.050 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.904350e-01 | 0.050 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.904350e-01 | 0.050 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.921418e-01 | 0.050 | 1 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.953700e-01 | 0.048 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.953700e-01 | 0.048 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.953700e-01 | 0.048 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.953700e-01 | 0.048 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.957447e-01 | 0.048 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.961657e-01 | 0.048 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.981592e-01 | 0.047 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.984369e-01 | 0.047 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.984515e-01 | 0.047 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.984515e-01 | 0.047 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.991164e-01 | 0.046 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.991164e-01 | 0.046 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.991164e-01 | 0.046 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.003963e-01 | 0.046 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.003963e-01 | 0.046 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.007361e-01 | 0.045 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.007361e-01 | 0.045 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.025270e-01 | 0.045 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 9.029718e-01 | 0.044 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 9.029718e-01 | 0.044 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 9.029718e-01 | 0.044 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 9.029718e-01 | 0.044 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 9.029718e-01 | 0.044 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 9.029718e-01 | 0.044 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 9.029718e-01 | 0.044 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 9.029718e-01 | 0.044 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 9.029718e-01 | 0.044 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 9.029718e-01 | 0.044 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 9.029718e-01 | 0.044 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 9.029718e-01 | 0.044 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.030619e-01 | 0.044 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.083854e-01 | 0.042 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.089859e-01 | 0.041 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.091342e-01 | 0.041 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.091342e-01 | 0.041 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.091342e-01 | 0.041 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.095606e-01 | 0.041 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.095606e-01 | 0.041 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.116131e-01 | 0.040 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.116131e-01 | 0.040 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.155950e-01 | 0.038 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 9.178704e-01 | 0.037 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 9.178704e-01 | 0.037 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 9.178704e-01 | 0.037 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 9.178704e-01 | 0.037 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 9.178704e-01 | 0.037 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 9.178704e-01 | 0.037 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 9.178704e-01 | 0.037 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 9.178704e-01 | 0.037 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.179773e-01 | 0.037 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.179773e-01 | 0.037 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.182574e-01 | 0.037 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.182574e-01 | 0.037 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.186345e-01 | 0.037 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.192852e-01 | 0.037 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.192852e-01 | 0.037 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.197883e-01 | 0.036 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.198717e-01 | 0.036 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.198717e-01 | 0.036 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.213953e-01 | 0.036 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.228423e-01 | 0.035 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.231711e-01 | 0.035 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.233205e-01 | 0.035 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.255091e-01 | 0.034 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.256947e-01 | 0.034 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.264281e-01 | 0.033 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.265514e-01 | 0.033 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.265514e-01 | 0.033 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.280995e-01 | 0.032 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.280995e-01 | 0.032 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.299915e-01 | 0.032 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.299915e-01 | 0.032 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.299915e-01 | 0.032 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.299915e-01 | 0.032 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 9.304820e-01 | 0.031 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 9.304820e-01 | 0.031 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.304820e-01 | 0.031 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 9.304820e-01 | 0.031 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 9.304820e-01 | 0.031 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 9.304820e-01 | 0.031 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 9.304820e-01 | 0.031 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.305466e-01 | 0.031 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.320404e-01 | 0.031 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.330084e-01 | 0.030 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.340790e-01 | 0.030 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.355854e-01 | 0.029 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.380479e-01 | 0.028 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.388936e-01 | 0.027 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.388936e-01 | 0.027 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.390618e-01 | 0.027 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.392176e-01 | 0.027 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.392176e-01 | 0.027 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.392176e-01 | 0.027 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.394150e-01 | 0.027 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.394150e-01 | 0.027 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.398586e-01 | 0.027 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.409000e-01 | 0.026 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.411577e-01 | 0.026 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.411577e-01 | 0.026 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 9.411577e-01 | 0.026 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 9.411577e-01 | 0.026 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.411577e-01 | 0.026 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.411577e-01 | 0.026 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.411577e-01 | 0.026 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.411577e-01 | 0.026 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.411577e-01 | 0.026 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.411577e-01 | 0.026 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.411577e-01 | 0.026 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 9.411577e-01 | 0.026 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.411577e-01 | 0.026 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.433605e-01 | 0.025 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.439284e-01 | 0.025 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.446229e-01 | 0.025 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.450736e-01 | 0.025 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.450736e-01 | 0.025 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.450736e-01 | 0.025 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.450736e-01 | 0.025 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.450905e-01 | 0.025 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.451120e-01 | 0.025 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.451120e-01 | 0.025 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.467132e-01 | 0.024 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.467132e-01 | 0.024 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.467132e-01 | 0.024 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.467132e-01 | 0.024 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.470714e-01 | 0.024 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.470714e-01 | 0.024 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.483919e-01 | 0.023 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.501944e-01 | 0.022 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.501944e-01 | 0.022 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.501944e-01 | 0.022 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.501944e-01 | 0.022 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.501944e-01 | 0.022 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 9.501944e-01 | 0.022 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.501944e-01 | 0.022 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.501944e-01 | 0.022 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.501944e-01 | 0.022 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.501944e-01 | 0.022 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.501944e-01 | 0.022 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.501944e-01 | 0.022 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.501944e-01 | 0.022 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.501944e-01 | 0.022 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.501944e-01 | 0.022 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.501944e-01 | 0.022 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.504845e-01 | 0.022 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.511194e-01 | 0.022 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.526469e-01 | 0.021 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.526469e-01 | 0.021 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.535728e-01 | 0.021 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.535728e-01 | 0.021 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.535728e-01 | 0.021 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.535728e-01 | 0.021 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.548199e-01 | 0.020 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.550027e-01 | 0.020 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.553747e-01 | 0.020 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.578437e-01 | 0.019 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.578437e-01 | 0.019 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.578437e-01 | 0.019 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.578437e-01 | 0.019 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.578437e-01 | 0.019 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.578437e-01 | 0.019 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.578437e-01 | 0.019 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.578437e-01 | 0.019 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.578437e-01 | 0.019 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.578437e-01 | 0.019 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.578437e-01 | 0.019 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 9.578437e-01 | 0.019 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.578437e-01 | 0.019 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.579343e-01 | 0.019 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.593177e-01 | 0.018 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.595828e-01 | 0.018 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.595828e-01 | 0.018 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.595828e-01 | 0.018 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.622335e-01 | 0.017 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.643186e-01 | 0.016 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.643186e-01 | 0.016 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.643186e-01 | 0.016 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.643186e-01 | 0.016 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.643186e-01 | 0.016 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.643186e-01 | 0.016 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.643186e-01 | 0.016 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.643186e-01 | 0.016 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.643186e-01 | 0.016 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.643186e-01 | 0.016 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.661573e-01 | 0.015 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.662867e-01 | 0.015 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.664479e-01 | 0.015 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.664479e-01 | 0.015 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.664479e-01 | 0.015 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.675153e-01 | 0.014 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.681010e-01 | 0.014 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.694124e-01 | 0.013 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.694401e-01 | 0.013 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.697993e-01 | 0.013 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.697993e-01 | 0.013 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.697993e-01 | 0.013 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.697993e-01 | 0.013 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.697993e-01 | 0.013 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.697993e-01 | 0.013 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.697993e-01 | 0.013 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.697993e-01 | 0.013 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.708297e-01 | 0.013 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.709211e-01 | 0.013 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.717440e-01 | 0.012 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.732412e-01 | 0.012 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.734552e-01 | 0.012 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.734552e-01 | 0.012 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.734552e-01 | 0.012 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.736866e-01 | 0.012 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.738282e-01 | 0.012 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.738327e-01 | 0.012 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.738611e-01 | 0.012 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.739134e-01 | 0.011 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.739134e-01 | 0.011 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.739134e-01 | 0.011 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.740614e-01 | 0.011 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.744385e-01 | 0.011 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.744385e-01 | 0.011 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.744385e-01 | 0.011 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.744385e-01 | 0.011 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.744385e-01 | 0.011 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.744385e-01 | 0.011 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.744385e-01 | 0.011 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.744385e-01 | 0.011 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.744385e-01 | 0.011 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.744385e-01 | 0.011 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.752598e-01 | 0.011 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.761907e-01 | 0.010 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.763592e-01 | 0.010 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.769582e-01 | 0.010 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.769582e-01 | 0.010 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.769582e-01 | 0.010 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.770262e-01 | 0.010 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.770262e-01 | 0.010 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.770262e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.770262e-01 | 0.010 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.770262e-01 | 0.010 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.770262e-01 | 0.010 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.772175e-01 | 0.010 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.772175e-01 | 0.010 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.772175e-01 | 0.010 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.778586e-01 | 0.010 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.782674e-01 | 0.010 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.783652e-01 | 0.009 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.783652e-01 | 0.009 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.783652e-01 | 0.009 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.783652e-01 | 0.009 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.783652e-01 | 0.009 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.783652e-01 | 0.009 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.783652e-01 | 0.009 | 0 | 0 |
| Biosynthesis of DHA-derived sulfido conjugates | R-HSA-9026395 | 9.783652e-01 | 0.009 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.783652e-01 | 0.009 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.783652e-01 | 0.009 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.789839e-01 | 0.009 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.797832e-01 | 0.009 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.800117e-01 | 0.009 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.816889e-01 | 0.008 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.816889e-01 | 0.008 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.816889e-01 | 0.008 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.816889e-01 | 0.008 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.816889e-01 | 0.008 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.816889e-01 | 0.008 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.817627e-01 | 0.008 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.826709e-01 | 0.008 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.826709e-01 | 0.008 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.834480e-01 | 0.007 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.836045e-01 | 0.007 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.840468e-01 | 0.007 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.845022e-01 | 0.007 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.845022e-01 | 0.007 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.845022e-01 | 0.007 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.845022e-01 | 0.007 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.845022e-01 | 0.007 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.845022e-01 | 0.007 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.847606e-01 | 0.007 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.849851e-01 | 0.007 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.849851e-01 | 0.007 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.851941e-01 | 0.006 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.862834e-01 | 0.006 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.862834e-01 | 0.006 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.865004e-01 | 0.006 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.868834e-01 | 0.006 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.868834e-01 | 0.006 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.868834e-01 | 0.006 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.868834e-01 | 0.006 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.868834e-01 | 0.006 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.868834e-01 | 0.006 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.868834e-01 | 0.006 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.868834e-01 | 0.006 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.868834e-01 | 0.006 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.878011e-01 | 0.005 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.880176e-01 | 0.005 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.884995e-01 | 0.005 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.884995e-01 | 0.005 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.887459e-01 | 0.005 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.888988e-01 | 0.005 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.888988e-01 | 0.005 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.888988e-01 | 0.005 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.888988e-01 | 0.005 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.890759e-01 | 0.005 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.897019e-01 | 0.004 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.897019e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.902642e-01 | 0.004 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.902642e-01 | 0.004 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.906046e-01 | 0.004 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.906046e-01 | 0.004 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.906046e-01 | 0.004 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.906046e-01 | 0.004 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.906046e-01 | 0.004 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.907498e-01 | 0.004 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.912162e-01 | 0.004 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.915085e-01 | 0.004 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.915818e-01 | 0.004 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.915818e-01 | 0.004 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.915818e-01 | 0.004 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.918982e-01 | 0.004 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.920484e-01 | 0.003 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.920484e-01 | 0.003 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.920484e-01 | 0.003 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.920484e-01 | 0.003 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.920484e-01 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.921563e-01 | 0.003 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.922717e-01 | 0.003 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.927244e-01 | 0.003 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.927244e-01 | 0.003 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.927244e-01 | 0.003 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.927244e-01 | 0.003 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.927244e-01 | 0.003 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.929082e-01 | 0.003 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.932036e-01 | 0.003 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.932261e-01 | 0.003 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.932704e-01 | 0.003 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.932704e-01 | 0.003 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.932704e-01 | 0.003 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.932704e-01 | 0.003 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.932704e-01 | 0.003 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.932704e-01 | 0.003 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.932853e-01 | 0.003 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.937147e-01 | 0.003 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.937248e-01 | 0.003 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.938676e-01 | 0.003 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.943047e-01 | 0.002 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.943047e-01 | 0.002 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.943047e-01 | 0.002 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.943047e-01 | 0.002 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.943047e-01 | 0.002 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.945198e-01 | 0.002 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.945725e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.945725e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.945725e-01 | 0.002 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.945753e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.946972e-01 | 0.002 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.951170e-01 | 0.002 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.951801e-01 | 0.002 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.951801e-01 | 0.002 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.951801e-01 | 0.002 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.951801e-01 | 0.002 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.951801e-01 | 0.002 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.952383e-01 | 0.002 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.952593e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.956963e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.956963e-01 | 0.002 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.958593e-01 | 0.002 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.959209e-01 | 0.002 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.959209e-01 | 0.002 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.959209e-01 | 0.002 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.959209e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.959209e-01 | 0.002 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.959209e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.959579e-01 | 0.002 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.959579e-01 | 0.002 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.959579e-01 | 0.002 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.962090e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.965137e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.965137e-01 | 0.002 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.965479e-01 | 0.002 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.965479e-01 | 0.002 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.966623e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.966623e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.967155e-01 | 0.001 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.968457e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.969942e-01 | 0.001 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.970786e-01 | 0.001 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.970786e-01 | 0.001 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.970786e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.970786e-01 | 0.001 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.970786e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.972739e-01 | 0.001 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.974094e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.977384e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.979078e-01 | 0.001 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.979078e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.979697e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.979995e-01 | 0.001 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.980775e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.981797e-01 | 0.001 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.982295e-01 | 0.001 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.982295e-01 | 0.001 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.982295e-01 | 0.001 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.983447e-01 | 0.001 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.984152e-01 | 0.001 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.985017e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.985017e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.985752e-01 | 0.001 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.985752e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.986080e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.986504e-01 | 0.001 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.987321e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.987711e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.989271e-01 | 0.000 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.989271e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.989453e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.989624e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.990907e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.990907e-01 | 0.000 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.990921e-01 | 0.000 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.990921e-01 | 0.000 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.990921e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.990921e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.990929e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.990930e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.992011e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.992119e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.992201e-01 | 0.000 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.992317e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.993297e-01 | 0.000 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.993499e-01 | 0.000 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.993499e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.993897e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.994240e-01 | 0.000 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.994499e-01 | 0.000 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.994499e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.994660e-01 | 0.000 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.995345e-01 | 0.000 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.995345e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.995345e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.995425e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.995749e-01 | 0.000 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.996061e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.996632e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.996632e-01 | 0.000 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.996667e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.996964e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.997129e-01 | 0.000 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.997180e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.997204e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.997204e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.997519e-01 | 0.000 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.997614e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.997692e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.997692e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.997822e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.997981e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.998292e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.998292e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.998356e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.998426e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.998472e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.998554e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.998648e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.998777e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.998934e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998955e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999087e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999173e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999173e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999207e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.999373e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.999384e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999399e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999417e-01 | 0.000 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.999470e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999505e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999576e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.999728e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999734e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999734e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.999770e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999805e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999825e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999833e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999841e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999852e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.999861e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999870e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999873e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999882e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999900e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999911e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999911e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999924e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999929e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999940e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999943e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999944e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999944e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999949e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999965e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999969e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999978e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999980e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999980e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999984e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999989e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999992e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999992e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999996e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999997e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 1.000000e+00 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 1 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 9.048318e-14 | 13.043 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.852962e-12 | 11.732 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.462741e-11 | 10.263 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.838741e-11 | 10.165 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.087129e-10 | 9.092 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.660385e-09 | 8.780 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.232510e-09 | 8.651 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.215299e-09 | 8.085 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.826759e-08 | 7.738 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.893207e-08 | 7.539 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.339861e-08 | 7.476 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.699300e-08 | 7.432 | 1 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 7.006646e-08 | 7.154 | 1 | 0 |
| M Phase | R-HSA-68886 | 9.951071e-08 | 7.002 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.453232e-07 | 6.838 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.687657e-07 | 6.329 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.699545e-07 | 6.244 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.489376e-06 | 5.827 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.688605e-06 | 5.772 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.719953e-06 | 5.764 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.649165e-06 | 5.577 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.833706e-06 | 5.548 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.815234e-06 | 5.550 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.996862e-06 | 5.523 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.047373e-06 | 5.393 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.147007e-06 | 5.288 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.419375e-06 | 5.266 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.212885e-06 | 5.283 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.711890e-06 | 5.060 | 1 | 1 |
| Cellular responses to stress | R-HSA-2262752 | 8.894918e-06 | 5.051 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.064305e-05 | 4.973 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.115308e-05 | 4.953 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.307659e-05 | 4.884 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.588375e-05 | 4.799 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.630435e-05 | 4.788 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.897077e-05 | 4.722 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.897077e-05 | 4.722 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.082161e-05 | 4.681 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.602038e-05 | 4.585 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.732307e-05 | 4.563 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.860600e-05 | 4.544 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.151081e-05 | 4.502 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.556994e-05 | 4.449 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.937351e-05 | 4.405 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.029542e-05 | 4.395 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.133686e-05 | 4.290 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.379946e-05 | 4.269 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.749729e-05 | 4.240 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.727871e-05 | 4.242 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.902885e-05 | 4.229 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.050093e-05 | 4.218 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.284182e-05 | 4.202 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.362344e-05 | 4.133 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.524302e-05 | 4.069 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.893656e-05 | 4.051 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.625785e-05 | 4.017 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.803864e-05 | 4.009 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.046976e-04 | 3.980 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.165223e-04 | 3.934 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.166024e-04 | 3.933 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.342347e-04 | 3.872 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.350995e-04 | 3.869 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.350995e-04 | 3.869 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.315753e-04 | 3.881 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.365297e-04 | 3.865 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.447099e-04 | 3.840 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.507532e-04 | 3.822 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.474833e-04 | 3.831 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.543699e-04 | 3.811 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.671154e-04 | 3.777 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.723846e-04 | 3.764 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.837221e-04 | 3.736 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.807311e-04 | 3.743 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.878285e-04 | 3.726 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.942023e-04 | 3.712 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.980888e-04 | 3.703 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.612609e-04 | 3.583 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.515714e-04 | 3.599 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.688149e-04 | 3.571 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.043138e-04 | 3.517 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.043138e-04 | 3.517 | 1 | 1 |
| Cell-Cell communication | R-HSA-1500931 | 2.882439e-04 | 3.540 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.036958e-04 | 3.518 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.130433e-04 | 3.504 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.147181e-04 | 3.502 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.151472e-04 | 3.501 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.587384e-04 | 3.445 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.490359e-04 | 3.457 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.769095e-04 | 3.424 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.893756e-04 | 3.410 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.197025e-04 | 3.377 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.208378e-04 | 3.376 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.651214e-04 | 3.332 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.051291e-04 | 3.297 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.351729e-04 | 3.272 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.376427e-04 | 3.270 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.401741e-04 | 3.267 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.669182e-04 | 3.246 | 1 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.031241e-04 | 3.220 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.192759e-04 | 3.208 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.179048e-04 | 3.209 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.289662e-04 | 3.201 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.560679e-04 | 3.183 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.591650e-04 | 3.181 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.609069e-04 | 3.180 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.137425e-04 | 3.146 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.839334e-04 | 3.165 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.137425e-04 | 3.146 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.799917e-04 | 3.167 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.264355e-04 | 3.139 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.537164e-04 | 3.123 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.457022e-04 | 3.073 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 9.012051e-04 | 3.045 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.104139e-04 | 3.041 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 9.511444e-04 | 3.022 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.837181e-04 | 3.007 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.837181e-04 | 3.007 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.857217e-04 | 3.006 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.102761e-03 | 2.958 | 1 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.111763e-03 | 2.954 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.194595e-03 | 2.923 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.222634e-03 | 2.913 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.194595e-03 | 2.923 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.194595e-03 | 2.923 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.241210e-03 | 2.906 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.393404e-03 | 2.856 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.472027e-03 | 2.832 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.480135e-03 | 2.830 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.564478e-03 | 2.806 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.564478e-03 | 2.806 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.578872e-03 | 2.802 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.588322e-03 | 2.799 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.661089e-03 | 2.780 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.661089e-03 | 2.780 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.661089e-03 | 2.780 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.748164e-03 | 2.757 | 1 | 1 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.761941e-03 | 2.754 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.761941e-03 | 2.754 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.791952e-03 | 2.747 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.798918e-03 | 2.745 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.833595e-03 | 2.737 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.847899e-03 | 2.733 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.977809e-03 | 2.704 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.040857e-03 | 2.690 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.172709e-03 | 2.663 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.097170e-03 | 2.678 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.317935e-03 | 2.635 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.317935e-03 | 2.635 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.317935e-03 | 2.635 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.317935e-03 | 2.635 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.131532e-03 | 2.671 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.317935e-03 | 2.635 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.298102e-03 | 2.639 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.214319e-03 | 2.655 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.248313e-03 | 2.648 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.395402e-03 | 2.621 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.482830e-03 | 2.605 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.482830e-03 | 2.605 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.482830e-03 | 2.605 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.482830e-03 | 2.605 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.567259e-03 | 2.591 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.604457e-03 | 2.584 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.651215e-03 | 2.577 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.850166e-03 | 2.545 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.866761e-03 | 2.543 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.350471e-03 | 2.475 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.350471e-03 | 2.475 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.350471e-03 | 2.475 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.104502e-03 | 2.508 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.104502e-03 | 2.508 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.350471e-03 | 2.475 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.112455e-03 | 2.507 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.678895e-03 | 2.434 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.998178e-03 | 2.398 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.025642e-03 | 2.395 | 1 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.252631e-03 | 2.371 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.252631e-03 | 2.371 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.282987e-03 | 2.368 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.608922e-03 | 2.336 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.692866e-03 | 2.329 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.692866e-03 | 2.329 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.692866e-03 | 2.329 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.467788e-03 | 2.262 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.633870e-03 | 2.249 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.755104e-03 | 2.170 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.755104e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.755104e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.755104e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.755104e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.755104e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.755104e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.755104e-03 | 2.170 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.755104e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.755104e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.755104e-03 | 2.170 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.088541e-03 | 2.215 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.446886e-03 | 2.191 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.072451e-03 | 2.217 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.162039e-03 | 2.210 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.659658e-03 | 2.177 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.092340e-03 | 2.215 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.876232e-03 | 2.163 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.899409e-03 | 2.161 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.904833e-03 | 2.161 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.131751e-03 | 2.147 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.585583e-03 | 2.066 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.942122e-03 | 2.100 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.942122e-03 | 2.100 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.585583e-03 | 2.066 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.562608e-03 | 2.067 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.479389e-03 | 2.072 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.915382e-03 | 2.102 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.420281e-03 | 2.075 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 8.585583e-03 | 2.066 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.908914e-03 | 2.102 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.915382e-03 | 2.102 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.942122e-03 | 2.100 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.420281e-03 | 2.075 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.029787e-03 | 2.095 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 7.428638e-03 | 2.129 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 7.428638e-03 | 2.129 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.932283e-03 | 2.101 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.643195e-03 | 2.063 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.808893e-03 | 2.055 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.894900e-03 | 2.051 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 9.114268e-03 | 2.040 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.132098e-03 | 2.039 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.556336e-03 | 2.020 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.623554e-03 | 2.017 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.623554e-03 | 2.017 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.012978e-02 | 1.994 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.012978e-02 | 1.994 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.012978e-02 | 1.994 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.012978e-02 | 1.994 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.017730e-02 | 1.992 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.021387e-02 | 1.991 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.027246e-02 | 1.988 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.060770e-02 | 1.974 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.060770e-02 | 1.974 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.063975e-02 | 1.973 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.106032e-02 | 1.956 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.106032e-02 | 1.956 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.109506e-02 | 1.955 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.130692e-02 | 1.947 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.130692e-02 | 1.947 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.130692e-02 | 1.947 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.130692e-02 | 1.947 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.130692e-02 | 1.947 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.130692e-02 | 1.947 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.149254e-02 | 1.940 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.231299e-02 | 1.910 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.480293e-02 | 1.830 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.283644e-02 | 1.892 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.283644e-02 | 1.892 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.283644e-02 | 1.892 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.435856e-02 | 1.843 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.435856e-02 | 1.843 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.240130e-02 | 1.907 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.443279e-02 | 1.841 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.389956e-02 | 1.857 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.480293e-02 | 1.830 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.352778e-02 | 1.869 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.275193e-02 | 1.894 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.483461e-02 | 1.829 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.483461e-02 | 1.829 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.545061e-02 | 1.811 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.545061e-02 | 1.811 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.545061e-02 | 1.811 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.545061e-02 | 1.811 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.570089e-02 | 1.804 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.570089e-02 | 1.804 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.570089e-02 | 1.804 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.570089e-02 | 1.804 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.570089e-02 | 1.804 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.570089e-02 | 1.804 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.581635e-02 | 1.801 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.581635e-02 | 1.801 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.597276e-02 | 1.797 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.684627e-02 | 1.773 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.692045e-02 | 1.772 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.729949e-02 | 1.762 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.753888e-02 | 1.756 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.842215e-02 | 1.735 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.871426e-02 | 1.728 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.133868e-02 | 1.671 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.895714e-02 | 1.722 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.895714e-02 | 1.722 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.895714e-02 | 1.722 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.895714e-02 | 1.722 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.895714e-02 | 1.722 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.895714e-02 | 1.722 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.895714e-02 | 1.722 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.970020e-02 | 1.706 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.009900e-02 | 1.697 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.992611e-02 | 1.701 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.992611e-02 | 1.701 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.248322e-02 | 1.648 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.339827e-02 | 1.631 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.170110e-02 | 1.664 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.935530e-02 | 1.713 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.986384e-02 | 1.702 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.986384e-02 | 1.702 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.170110e-02 | 1.664 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.291832e-02 | 1.640 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.071263e-02 | 1.684 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.262673e-02 | 1.645 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.133868e-02 | 1.671 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.262673e-02 | 1.645 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.071263e-02 | 1.684 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.095435e-02 | 1.679 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.213126e-02 | 1.655 | 1 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.133868e-02 | 1.671 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.248322e-02 | 1.648 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.935530e-02 | 1.713 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.133868e-02 | 1.671 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.895205e-02 | 1.722 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.133868e-02 | 1.671 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.372193e-02 | 1.625 | 1 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.381195e-02 | 1.623 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.552441e-02 | 1.593 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.600935e-02 | 1.585 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.620978e-02 | 1.582 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.663264e-02 | 1.575 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.670047e-02 | 1.573 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.750113e-02 | 1.561 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.797164e-02 | 1.553 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.811311e-02 | 1.551 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.811311e-02 | 1.551 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.811311e-02 | 1.551 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.817939e-02 | 1.550 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.825088e-02 | 1.549 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.870441e-02 | 1.542 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.897251e-02 | 1.538 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.940272e-02 | 1.532 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.940272e-02 | 1.532 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.945886e-02 | 1.531 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.945886e-02 | 1.531 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.945886e-02 | 1.531 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.969470e-02 | 1.527 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.996889e-02 | 1.523 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.129024e-02 | 1.505 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.108310e-02 | 1.386 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.603018e-02 | 1.443 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.575743e-02 | 1.447 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.575743e-02 | 1.447 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.575743e-02 | 1.447 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.575743e-02 | 1.447 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.289649e-02 | 1.368 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.309835e-02 | 1.480 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.935842e-02 | 1.405 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.935842e-02 | 1.405 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.048413e-02 | 1.393 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.048413e-02 | 1.393 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.430107e-02 | 1.465 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.131655e-02 | 1.384 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.879764e-02 | 1.411 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.702766e-02 | 1.431 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.879764e-02 | 1.411 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.430107e-02 | 1.465 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.108310e-02 | 1.386 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 3.575743e-02 | 1.447 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.408259e-02 | 1.467 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 4.289649e-02 | 1.368 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.309835e-02 | 1.480 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.321789e-02 | 1.479 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.575743e-02 | 1.447 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.575743e-02 | 1.447 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.289649e-02 | 1.368 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.413254e-02 | 1.467 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.899522e-02 | 1.409 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.399972e-02 | 1.469 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.108310e-02 | 1.386 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.108310e-02 | 1.386 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.510432e-02 | 1.455 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.935842e-02 | 1.405 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.131655e-02 | 1.384 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.722714e-02 | 1.429 | 1 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.408259e-02 | 1.467 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.706282e-02 | 1.431 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.702766e-02 | 1.431 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.561462e-02 | 1.448 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.879764e-02 | 1.411 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.408259e-02 | 1.467 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.342123e-02 | 1.362 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.342123e-02 | 1.362 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.342123e-02 | 1.362 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.342123e-02 | 1.362 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.379180e-02 | 1.359 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.490088e-02 | 1.348 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.508492e-02 | 1.346 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.592842e-02 | 1.338 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.733029e-02 | 1.325 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.733029e-02 | 1.325 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.795270e-02 | 1.319 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.797669e-02 | 1.319 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.083273e-02 | 1.294 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.083273e-02 | 1.294 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.087442e-02 | 1.294 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.197158e-02 | 1.284 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.205786e-02 | 1.284 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.430639e-02 | 1.265 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.467053e-02 | 1.262 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.467053e-02 | 1.262 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.534136e-02 | 1.257 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.546033e-02 | 1.256 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.614986e-02 | 1.251 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.735134e-02 | 1.241 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.735134e-02 | 1.241 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.825920e-02 | 1.235 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.829318e-02 | 1.234 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.847731e-02 | 1.233 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.957153e-02 | 1.225 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.957153e-02 | 1.225 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.970372e-02 | 1.224 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.970372e-02 | 1.224 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.034747e-02 | 1.219 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.034747e-02 | 1.219 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.135469e-02 | 1.212 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.177109e-02 | 1.209 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.177109e-02 | 1.209 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.177347e-02 | 1.209 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.177347e-02 | 1.209 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.177347e-02 | 1.209 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.177347e-02 | 1.209 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.177347e-02 | 1.209 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.213492e-02 | 1.207 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.242057e-02 | 1.205 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 9.002047e-02 | 1.046 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 9.002047e-02 | 1.046 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 9.002047e-02 | 1.046 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 9.002047e-02 | 1.046 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 9.002047e-02 | 1.046 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 9.002047e-02 | 1.046 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.002047e-02 | 1.046 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 9.002047e-02 | 1.046 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.011676e-02 | 1.154 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.011676e-02 | 1.154 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.011676e-02 | 1.154 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 8.728942e-02 | 1.059 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.728942e-02 | 1.059 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.671922e-02 | 1.176 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.671922e-02 | 1.176 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.944266e-02 | 1.100 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 9.055127e-02 | 1.043 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.628191e-02 | 1.118 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.628191e-02 | 1.118 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.431566e-02 | 1.192 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.431566e-02 | 1.192 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.560033e-02 | 1.068 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.971596e-02 | 1.098 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.350146e-02 | 1.134 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.609046e-02 | 1.065 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.609046e-02 | 1.065 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.722083e-02 | 1.059 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.155137e-02 | 1.038 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.379056e-02 | 1.028 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.911106e-02 | 1.160 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.070976e-02 | 1.151 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.177036e-02 | 1.144 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.091484e-02 | 1.092 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.055127e-02 | 1.043 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.971596e-02 | 1.098 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.560033e-02 | 1.068 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.072247e-02 | 1.093 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.879230e-02 | 1.052 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.879230e-02 | 1.052 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 8.170802e-02 | 1.088 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.944266e-02 | 1.100 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.103685e-02 | 1.091 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.722083e-02 | 1.059 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.756867e-02 | 1.170 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.756867e-02 | 1.170 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.055127e-02 | 1.043 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.799005e-02 | 1.108 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.801264e-02 | 1.108 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.543567e-02 | 1.122 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.685566e-02 | 1.114 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.091484e-02 | 1.092 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.374090e-02 | 1.077 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.092331e-02 | 1.041 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.396737e-02 | 1.076 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.756867e-02 | 1.170 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.177036e-02 | 1.144 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.091484e-02 | 1.092 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.560033e-02 | 1.068 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.011676e-02 | 1.154 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.815052e-02 | 1.055 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.799005e-02 | 1.108 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.799005e-02 | 1.108 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.982909e-02 | 1.156 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.685566e-02 | 1.114 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.671922e-02 | 1.176 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.671922e-02 | 1.176 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.364961e-02 | 1.133 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.691018e-02 | 1.175 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.971596e-02 | 1.098 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.284561e-02 | 1.032 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.671922e-02 | 1.176 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.560033e-02 | 1.068 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.911106e-02 | 1.160 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.551582e-02 | 1.020 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.551582e-02 | 1.020 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.665812e-02 | 1.015 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.706973e-02 | 1.013 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.706973e-02 | 1.013 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.933875e-02 | 1.003 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.945119e-02 | 1.002 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.990725e-02 | 1.000 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.024159e-01 | 0.990 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.024159e-01 | 0.990 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.028290e-01 | 0.988 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.060168e-01 | 0.975 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.060168e-01 | 0.975 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.060369e-01 | 0.975 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.060369e-01 | 0.975 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.060369e-01 | 0.975 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.060369e-01 | 0.975 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.064669e-01 | 0.973 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.064669e-01 | 0.973 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.064669e-01 | 0.973 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.072737e-01 | 0.970 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.072737e-01 | 0.970 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.088488e-01 | 0.963 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.095299e-01 | 0.960 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.095563e-01 | 0.960 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.108057e-01 | 0.955 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.108057e-01 | 0.955 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.108057e-01 | 0.955 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.134496e-01 | 0.945 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.149426e-01 | 0.940 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.150102e-01 | 0.939 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.150102e-01 | 0.939 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.150102e-01 | 0.939 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.170882e-01 | 0.931 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.170882e-01 | 0.931 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.170882e-01 | 0.931 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.170882e-01 | 0.931 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.192984e-01 | 0.923 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.192984e-01 | 0.923 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.192984e-01 | 0.923 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.207880e-01 | 0.918 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.222947e-01 | 0.913 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.228772e-01 | 0.911 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.228990e-01 | 0.910 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.228990e-01 | 0.910 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.233166e-01 | 0.909 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.233166e-01 | 0.909 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.233166e-01 | 0.909 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.253210e-01 | 0.902 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.253210e-01 | 0.902 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.261953e-01 | 0.899 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.261953e-01 | 0.899 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.261953e-01 | 0.899 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.266577e-01 | 0.897 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.276646e-01 | 0.894 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.280400e-01 | 0.893 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.280400e-01 | 0.893 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.283030e-01 | 0.892 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.283030e-01 | 0.892 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.283030e-01 | 0.892 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.283030e-01 | 0.892 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.283030e-01 | 0.892 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.287121e-01 | 0.890 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.287121e-01 | 0.890 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.289056e-01 | 0.890 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.289056e-01 | 0.890 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.299109e-01 | 0.886 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.311730e-01 | 0.882 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.342784e-01 | 0.872 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.342784e-01 | 0.872 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.342784e-01 | 0.872 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.343390e-01 | 0.872 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.347571e-01 | 0.870 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.374273e-01 | 0.862 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.393340e-01 | 0.856 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.393340e-01 | 0.856 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.393340e-01 | 0.856 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.396357e-01 | 0.855 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.400156e-01 | 0.854 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.408678e-01 | 0.851 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.408678e-01 | 0.851 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.417087e-01 | 0.849 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 1.421079e-01 | 0.847 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.421079e-01 | 0.847 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.421079e-01 | 0.847 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.421079e-01 | 0.847 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.430072e-01 | 0.845 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.430072e-01 | 0.845 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.430072e-01 | 0.845 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.430072e-01 | 0.845 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.442173e-01 | 0.841 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.465047e-01 | 0.834 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.475941e-01 | 0.831 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.485611e-01 | 0.828 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.534016e-01 | 0.814 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.535317e-01 | 0.814 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.548577e-01 | 0.810 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.562118e-01 | 0.806 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.562118e-01 | 0.806 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.565888e-01 | 0.805 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.581816e-01 | 0.801 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.719421e-01 | 0.765 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.719421e-01 | 0.765 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.719421e-01 | 0.765 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.719421e-01 | 0.765 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.719421e-01 | 0.765 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.464931e-01 | 0.608 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.464931e-01 | 0.608 | 0 | 0 |
| Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | R-HSA-5619045 | 2.464931e-01 | 0.608 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.464931e-01 | 0.608 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 2.464931e-01 | 0.608 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.464931e-01 | 0.608 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.464931e-01 | 0.608 | 0 | 0 |
| Defective SLC34A2 causes PALM | R-HSA-5687583 | 2.464931e-01 | 0.608 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.464931e-01 | 0.608 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.464931e-01 | 0.608 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.464931e-01 | 0.608 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.749827e-01 | 0.757 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.749827e-01 | 0.757 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.749827e-01 | 0.757 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.143362e-01 | 0.503 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.143362e-01 | 0.503 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.143362e-01 | 0.503 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.143362e-01 | 0.503 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.143362e-01 | 0.503 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.143362e-01 | 0.503 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.088937e-01 | 0.680 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.088937e-01 | 0.680 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.088937e-01 | 0.680 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.700612e-01 | 0.769 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.700612e-01 | 0.769 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.433883e-01 | 0.614 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.433883e-01 | 0.614 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.934258e-01 | 0.713 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.780869e-01 | 0.556 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.780869e-01 | 0.556 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.780869e-01 | 0.556 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.175218e-01 | 0.662 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.745870e-01 | 0.758 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.421897e-01 | 0.616 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.421897e-01 | 0.616 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.421897e-01 | 0.616 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.126736e-01 | 0.505 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.126736e-01 | 0.505 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.126736e-01 | 0.505 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.926457e-01 | 0.534 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.926457e-01 | 0.534 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.926457e-01 | 0.534 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.205264e-01 | 0.657 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.205264e-01 | 0.657 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.943069e-01 | 0.712 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.181601e-01 | 0.497 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.549290e-01 | 0.594 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.765281e-01 | 0.753 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.386287e-01 | 0.622 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.103382e-01 | 0.677 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.146878e-01 | 0.502 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.226104e-01 | 0.652 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.226104e-01 | 0.652 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.514350e-01 | 0.600 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.733492e-01 | 0.761 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.479012e-01 | 0.606 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.694132e-01 | 0.771 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.608826e-01 | 0.584 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.620806e-01 | 0.582 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.929441e-01 | 0.533 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.056048e-01 | 0.515 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.485112e-01 | 0.605 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.713969e-01 | 0.766 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.890777e-01 | 0.539 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.516047e-01 | 0.599 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.516047e-01 | 0.599 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.787612e-01 | 0.748 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.787612e-01 | 0.748 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.009390e-01 | 0.522 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.375024e-01 | 0.624 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.787612e-01 | 0.748 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.126736e-01 | 0.505 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.375024e-01 | 0.624 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.700612e-01 | 0.769 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.238322e-01 | 0.650 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.375024e-01 | 0.624 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 2.780869e-01 | 0.556 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.672783e-01 | 0.573 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.745870e-01 | 0.758 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.780869e-01 | 0.556 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.126736e-01 | 0.505 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.124956e-01 | 0.673 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.722499e-01 | 0.764 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.745870e-01 | 0.758 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.386287e-01 | 0.622 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.725989e-01 | 0.564 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.167570e-01 | 0.664 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.877012e-01 | 0.727 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.666782e-01 | 0.778 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.620498e-01 | 0.790 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.752268e-01 | 0.756 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.983389e-01 | 0.703 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.285104e-01 | 0.641 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.719421e-01 | 0.765 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.126736e-01 | 0.505 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.602408e-01 | 0.795 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.017137e-01 | 0.520 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 3.009390e-01 | 0.522 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.177040e-01 | 0.662 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.320429e-01 | 0.634 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.175218e-01 | 0.662 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.846350e-01 | 0.734 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 2.780869e-01 | 0.556 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.877012e-01 | 0.727 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.943069e-01 | 0.712 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.697141e-01 | 0.569 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.071089e-01 | 0.684 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.993918e-01 | 0.524 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.720014e-01 | 0.764 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.697141e-01 | 0.569 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.288653e-01 | 0.640 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.038921e-01 | 0.691 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.672201e-01 | 0.573 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.846350e-01 | 0.734 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.177040e-01 | 0.662 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.725989e-01 | 0.564 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.672201e-01 | 0.573 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.214441e-01 | 0.655 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.596439e-01 | 0.797 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.926457e-01 | 0.534 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.666782e-01 | 0.778 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.779793e-01 | 0.556 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.719421e-01 | 0.765 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.464931e-01 | 0.608 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.464931e-01 | 0.608 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.749827e-01 | 0.757 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.749827e-01 | 0.757 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.143362e-01 | 0.503 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 3.143362e-01 | 0.503 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.175218e-01 | 0.662 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 1.932494e-01 | 0.714 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.943069e-01 | 0.712 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.181601e-01 | 0.497 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.937135e-01 | 0.532 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.375024e-01 | 0.624 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.226104e-01 | 0.652 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.090904e-01 | 0.680 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.351375e-01 | 0.629 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.259559e-01 | 0.646 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.608044e-01 | 0.794 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.666782e-01 | 0.778 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.396205e-01 | 0.620 | 1 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.597860e-01 | 0.585 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.856166e-01 | 0.544 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.601488e-01 | 0.795 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.181601e-01 | 0.497 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.086314e-01 | 0.511 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.641459e-01 | 0.785 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.088937e-01 | 0.680 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.433883e-01 | 0.614 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.934258e-01 | 0.713 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.934258e-01 | 0.713 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.934258e-01 | 0.713 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.126736e-01 | 0.505 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.672783e-01 | 0.573 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.421897e-01 | 0.616 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.104486e-01 | 0.677 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.749827e-01 | 0.757 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.143362e-01 | 0.503 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.181601e-01 | 0.497 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.086314e-01 | 0.511 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.375024e-01 | 0.624 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.863981e-01 | 0.543 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.175218e-01 | 0.662 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.126736e-01 | 0.505 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.672783e-01 | 0.573 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.322446e-01 | 0.634 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.741657e-01 | 0.562 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.937135e-01 | 0.532 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.722499e-01 | 0.764 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.697141e-01 | 0.569 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.086314e-01 | 0.511 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.038921e-01 | 0.691 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.146878e-01 | 0.502 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.126736e-01 | 0.505 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.672783e-01 | 0.573 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.322446e-01 | 0.634 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.126736e-01 | 0.505 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.485112e-01 | 0.605 | 1 | 1 |
| HDL assembly | R-HSA-8963896 | 2.421897e-01 | 0.616 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.179714e-01 | 0.498 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.183886e-01 | 0.497 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.241557e-01 | 0.489 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.268985e-01 | 0.486 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.268985e-01 | 0.486 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.268985e-01 | 0.486 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.326562e-01 | 0.478 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.343564e-01 | 0.476 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.347112e-01 | 0.475 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.354217e-01 | 0.474 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.354217e-01 | 0.474 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.354217e-01 | 0.474 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.354217e-01 | 0.474 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.356741e-01 | 0.474 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.357833e-01 | 0.474 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.357833e-01 | 0.474 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.394105e-01 | 0.469 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.416818e-01 | 0.466 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.422494e-01 | 0.466 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.422494e-01 | 0.466 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.422494e-01 | 0.466 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.437002e-01 | 0.464 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.437002e-01 | 0.464 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.437002e-01 | 0.464 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.437002e-01 | 0.464 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.452710e-01 | 0.462 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.452710e-01 | 0.462 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.452710e-01 | 0.462 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.461769e-01 | 0.461 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.464782e-01 | 0.460 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.468873e-01 | 0.460 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.468873e-01 | 0.460 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.468873e-01 | 0.460 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.468873e-01 | 0.460 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.468873e-01 | 0.460 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.468873e-01 | 0.460 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.468873e-01 | 0.460 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.468873e-01 | 0.460 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.508361e-01 | 0.455 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.508361e-01 | 0.455 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.569321e-01 | 0.447 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.569321e-01 | 0.447 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.578678e-01 | 0.446 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.637044e-01 | 0.439 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.637044e-01 | 0.439 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.654318e-01 | 0.437 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.687734e-01 | 0.433 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.691553e-01 | 0.433 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.691553e-01 | 0.433 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.691553e-01 | 0.433 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.691553e-01 | 0.433 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.691553e-01 | 0.433 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.703718e-01 | 0.431 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.704340e-01 | 0.431 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.704340e-01 | 0.431 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.760746e-01 | 0.425 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.760746e-01 | 0.425 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.760746e-01 | 0.425 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.760746e-01 | 0.425 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.760746e-01 | 0.425 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.760746e-01 | 0.425 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.760746e-01 | 0.425 | 0 | 0 |
| Type II Na+/Pi cotransporters | R-HSA-427589 | 3.760746e-01 | 0.425 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.760746e-01 | 0.425 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.763671e-01 | 0.424 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.769619e-01 | 0.424 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.769619e-01 | 0.424 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.780703e-01 | 0.422 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.780703e-01 | 0.422 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.805151e-01 | 0.420 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.805151e-01 | 0.420 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.805151e-01 | 0.420 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.821560e-01 | 0.418 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.839519e-01 | 0.416 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.839519e-01 | 0.416 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.839519e-01 | 0.416 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.839519e-01 | 0.416 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.892861e-01 | 0.410 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.892861e-01 | 0.410 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.944256e-01 | 0.404 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.944256e-01 | 0.404 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.950281e-01 | 0.403 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.991378e-01 | 0.399 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.991378e-01 | 0.399 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.991378e-01 | 0.399 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.996736e-01 | 0.398 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.996736e-01 | 0.398 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.005268e-01 | 0.397 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.074872e-01 | 0.390 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.080729e-01 | 0.389 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.080729e-01 | 0.389 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.098393e-01 | 0.387 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 4.099815e-01 | 0.387 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.124512e-01 | 0.385 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.133852e-01 | 0.384 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.133852e-01 | 0.384 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.133852e-01 | 0.384 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.153560e-01 | 0.382 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.168351e-01 | 0.380 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.168351e-01 | 0.380 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.170739e-01 | 0.380 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.170739e-01 | 0.380 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.189515e-01 | 0.378 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.189515e-01 | 0.378 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.194212e-01 | 0.377 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 4.199522e-01 | 0.377 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.200785e-01 | 0.377 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.200785e-01 | 0.377 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.231800e-01 | 0.373 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.253968e-01 | 0.371 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.322573e-01 | 0.364 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.322573e-01 | 0.364 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.322573e-01 | 0.364 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 4.322573e-01 | 0.364 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.322573e-01 | 0.364 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.322573e-01 | 0.364 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.322573e-01 | 0.364 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.322573e-01 | 0.364 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.322573e-01 | 0.364 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.322573e-01 | 0.364 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.322573e-01 | 0.364 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.322573e-01 | 0.364 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.322573e-01 | 0.364 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.322938e-01 | 0.364 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.324108e-01 | 0.364 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.325618e-01 | 0.364 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.372197e-01 | 0.359 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.372197e-01 | 0.359 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.372197e-01 | 0.359 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.405041e-01 | 0.356 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.408409e-01 | 0.356 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.408409e-01 | 0.356 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.408409e-01 | 0.356 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 4.408409e-01 | 0.356 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.440629e-01 | 0.353 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.440629e-01 | 0.353 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.453615e-01 | 0.351 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.453615e-01 | 0.351 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.453615e-01 | 0.351 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.453615e-01 | 0.351 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.495134e-01 | 0.347 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.499748e-01 | 0.347 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.553545e-01 | 0.342 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.553545e-01 | 0.342 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.553545e-01 | 0.342 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.589737e-01 | 0.338 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.626205e-01 | 0.335 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.659866e-01 | 0.332 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.684958e-01 | 0.329 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.684958e-01 | 0.329 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.702101e-01 | 0.328 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.733237e-01 | 0.325 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.750316e-01 | 0.323 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.763386e-01 | 0.322 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.763386e-01 | 0.322 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.763386e-01 | 0.322 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.763386e-01 | 0.322 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.763386e-01 | 0.322 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.802000e-01 | 0.319 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.819429e-01 | 0.317 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 4.833839e-01 | 0.316 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.833839e-01 | 0.316 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.833839e-01 | 0.316 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.833839e-01 | 0.316 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.833839e-01 | 0.316 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.833839e-01 | 0.316 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.833839e-01 | 0.316 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.833839e-01 | 0.316 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.833839e-01 | 0.316 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.833839e-01 | 0.316 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.854895e-01 | 0.314 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.864747e-01 | 0.313 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.875246e-01 | 0.312 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.910970e-01 | 0.309 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.910970e-01 | 0.309 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.920140e-01 | 0.308 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.938827e-01 | 0.306 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.961284e-01 | 0.304 | 1 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.984645e-01 | 0.302 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.984645e-01 | 0.302 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.994250e-01 | 0.302 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.016023e-01 | 0.300 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.016023e-01 | 0.300 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.016023e-01 | 0.300 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.062372e-01 | 0.296 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.062372e-01 | 0.296 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.062372e-01 | 0.296 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.086465e-01 | 0.294 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.146949e-01 | 0.288 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.148128e-01 | 0.288 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.152110e-01 | 0.288 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.152110e-01 | 0.288 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.184636e-01 | 0.285 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.190973e-01 | 0.285 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.212167e-01 | 0.283 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.259468e-01 | 0.279 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.261300e-01 | 0.279 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.299092e-01 | 0.276 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.299092e-01 | 0.276 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.299092e-01 | 0.276 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.299092e-01 | 0.276 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.299092e-01 | 0.276 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.299092e-01 | 0.276 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.299092e-01 | 0.276 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.299092e-01 | 0.276 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.299092e-01 | 0.276 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.299092e-01 | 0.276 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.299092e-01 | 0.276 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 5.299092e-01 | 0.276 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.299092e-01 | 0.276 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.299092e-01 | 0.276 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.299092e-01 | 0.276 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.304627e-01 | 0.275 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.304627e-01 | 0.275 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.336154e-01 | 0.273 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.350002e-01 | 0.272 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.350002e-01 | 0.272 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.350002e-01 | 0.272 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.350002e-01 | 0.272 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.366851e-01 | 0.270 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.378278e-01 | 0.269 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.378278e-01 | 0.269 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.378278e-01 | 0.269 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.391482e-01 | 0.268 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.404561e-01 | 0.267 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.404561e-01 | 0.267 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.598281e-01 | 0.252 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.598281e-01 | 0.252 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 5.598281e-01 | 0.252 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.599481e-01 | 0.252 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.625899e-01 | 0.250 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.625899e-01 | 0.250 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.625899e-01 | 0.250 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.625899e-01 | 0.250 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.625899e-01 | 0.250 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.625899e-01 | 0.250 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.625899e-01 | 0.250 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.625899e-01 | 0.250 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.722471e-01 | 0.242 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.722471e-01 | 0.242 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.722471e-01 | 0.242 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.722471e-01 | 0.242 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.722471e-01 | 0.242 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.722471e-01 | 0.242 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.722471e-01 | 0.242 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.722471e-01 | 0.242 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.722471e-01 | 0.242 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.722471e-01 | 0.242 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.722471e-01 | 0.242 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 5.777038e-01 | 0.238 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.792088e-01 | 0.237 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.811826e-01 | 0.236 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.813029e-01 | 0.236 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.819612e-01 | 0.235 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.822146e-01 | 0.235 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.880489e-01 | 0.231 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.889842e-01 | 0.230 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.889842e-01 | 0.230 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.951693e-01 | 0.225 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.002706e-01 | 0.222 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.004735e-01 | 0.222 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.009186e-01 | 0.221 | 1 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.018684e-01 | 0.220 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.018684e-01 | 0.220 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 6.018684e-01 | 0.220 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.018684e-01 | 0.220 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.046948e-01 | 0.218 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.067858e-01 | 0.217 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.079710e-01 | 0.216 | 1 | 1 |
| Metal ion SLC transporters | R-HSA-425410 | 6.079710e-01 | 0.216 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.099115e-01 | 0.215 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.107741e-01 | 0.214 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.107741e-01 | 0.214 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.107741e-01 | 0.214 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.107741e-01 | 0.214 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.107741e-01 | 0.214 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.107741e-01 | 0.214 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.107741e-01 | 0.214 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.107741e-01 | 0.214 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.107741e-01 | 0.214 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.107741e-01 | 0.214 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.107741e-01 | 0.214 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.107741e-01 | 0.214 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.107741e-01 | 0.214 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.107741e-01 | 0.214 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.107741e-01 | 0.214 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.107741e-01 | 0.214 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.107741e-01 | 0.214 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.107741e-01 | 0.214 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.131683e-01 | 0.212 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.131683e-01 | 0.212 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.141746e-01 | 0.212 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.141746e-01 | 0.212 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.141746e-01 | 0.212 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.141746e-01 | 0.212 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.141746e-01 | 0.212 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.218684e-01 | 0.206 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.218684e-01 | 0.206 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.218684e-01 | 0.206 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.236395e-01 | 0.205 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.236395e-01 | 0.205 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.257718e-01 | 0.204 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.286839e-01 | 0.202 | 1 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.327055e-01 | 0.199 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.366502e-01 | 0.196 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.368284e-01 | 0.196 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.381639e-01 | 0.195 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.383866e-01 | 0.195 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.383866e-01 | 0.195 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.411707e-01 | 0.193 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.411707e-01 | 0.193 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.411707e-01 | 0.193 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.411707e-01 | 0.193 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.435045e-01 | 0.191 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.458332e-01 | 0.190 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.458332e-01 | 0.190 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.458332e-01 | 0.190 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.458332e-01 | 0.190 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.458332e-01 | 0.190 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.458332e-01 | 0.190 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.458332e-01 | 0.190 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.458332e-01 | 0.190 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.467253e-01 | 0.189 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.467253e-01 | 0.189 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.467253e-01 | 0.189 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.530339e-01 | 0.185 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.597683e-01 | 0.181 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.597683e-01 | 0.181 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.609641e-01 | 0.180 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.609641e-01 | 0.180 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.609641e-01 | 0.180 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.609641e-01 | 0.180 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.627625e-01 | 0.179 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.670770e-01 | 0.176 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.672973e-01 | 0.176 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.724552e-01 | 0.172 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.777362e-01 | 0.169 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.777362e-01 | 0.169 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.777362e-01 | 0.169 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 6.777362e-01 | 0.169 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.777362e-01 | 0.169 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.777362e-01 | 0.169 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.777362e-01 | 0.169 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.777362e-01 | 0.169 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.777362e-01 | 0.169 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.777362e-01 | 0.169 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.777362e-01 | 0.169 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.811711e-01 | 0.167 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.825946e-01 | 0.166 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.825946e-01 | 0.166 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.825946e-01 | 0.166 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.825946e-01 | 0.166 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.825946e-01 | 0.166 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.825946e-01 | 0.166 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.825946e-01 | 0.166 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.825946e-01 | 0.166 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.838146e-01 | 0.165 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.850750e-01 | 0.164 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.897276e-01 | 0.161 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.946510e-01 | 0.158 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.948418e-01 | 0.158 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.955790e-01 | 0.158 | 1 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.964432e-01 | 0.157 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.988448e-01 | 0.156 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.008319e-01 | 0.154 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.030813e-01 | 0.153 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.030813e-01 | 0.153 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.067672e-01 | 0.151 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.067672e-01 | 0.151 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.067672e-01 | 0.151 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.067672e-01 | 0.151 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.067672e-01 | 0.151 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.067672e-01 | 0.151 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.067672e-01 | 0.151 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.067672e-01 | 0.151 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.067672e-01 | 0.151 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 7.067672e-01 | 0.151 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.078454e-01 | 0.150 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.113231e-01 | 0.148 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.129542e-01 | 0.147 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.150326e-01 | 0.146 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.184843e-01 | 0.144 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.204197e-01 | 0.142 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.209886e-01 | 0.142 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.209886e-01 | 0.142 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.224545e-01 | 0.141 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.251293e-01 | 0.140 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.271094e-01 | 0.138 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.271094e-01 | 0.138 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.327069e-01 | 0.135 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.331845e-01 | 0.135 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.331845e-01 | 0.135 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.331845e-01 | 0.135 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.331845e-01 | 0.135 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.331845e-01 | 0.135 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.331845e-01 | 0.135 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.331845e-01 | 0.135 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.331845e-01 | 0.135 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.331845e-01 | 0.135 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.331845e-01 | 0.135 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.331845e-01 | 0.135 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.331845e-01 | 0.135 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.353670e-01 | 0.133 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.353670e-01 | 0.133 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.407486e-01 | 0.130 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.483746e-01 | 0.126 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.483746e-01 | 0.126 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.483746e-01 | 0.126 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.539515e-01 | 0.123 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.539552e-01 | 0.123 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.566388e-01 | 0.121 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.572233e-01 | 0.121 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.572233e-01 | 0.121 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.572233e-01 | 0.121 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.572233e-01 | 0.121 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.572233e-01 | 0.121 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.572233e-01 | 0.121 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.572233e-01 | 0.121 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.572233e-01 | 0.121 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.580008e-01 | 0.120 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.580008e-01 | 0.120 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.580008e-01 | 0.120 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.580008e-01 | 0.120 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.580008e-01 | 0.120 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.580008e-01 | 0.120 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.608867e-01 | 0.119 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.619262e-01 | 0.118 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.642842e-01 | 0.117 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.671946e-01 | 0.115 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.704078e-01 | 0.113 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.704078e-01 | 0.113 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.704078e-01 | 0.113 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.704078e-01 | 0.113 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.729100e-01 | 0.112 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.729100e-01 | 0.112 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.731212e-01 | 0.112 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.742923e-01 | 0.111 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 7.790976e-01 | 0.108 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 7.790976e-01 | 0.108 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.790976e-01 | 0.108 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.790976e-01 | 0.108 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.790976e-01 | 0.108 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.790976e-01 | 0.108 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.790976e-01 | 0.108 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.790976e-01 | 0.108 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.790976e-01 | 0.108 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.790976e-01 | 0.108 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.790976e-01 | 0.108 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.790976e-01 | 0.108 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.790976e-01 | 0.108 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.790976e-01 | 0.108 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.790976e-01 | 0.108 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.798637e-01 | 0.108 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.805820e-01 | 0.108 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.820092e-01 | 0.107 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.844522e-01 | 0.105 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.864656e-01 | 0.104 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.884041e-01 | 0.103 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.889722e-01 | 0.103 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.895375e-01 | 0.103 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.895375e-01 | 0.103 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.895375e-01 | 0.103 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.895375e-01 | 0.103 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.895375e-01 | 0.103 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.895375e-01 | 0.103 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.960316e-01 | 0.099 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.981934e-01 | 0.098 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.990022e-01 | 0.097 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.990022e-01 | 0.097 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 7.990022e-01 | 0.097 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.990022e-01 | 0.097 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.990022e-01 | 0.097 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.990022e-01 | 0.097 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.990022e-01 | 0.097 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.039040e-01 | 0.095 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.061294e-01 | 0.094 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.066708e-01 | 0.093 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.077744e-01 | 0.093 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.079210e-01 | 0.093 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.101230e-01 | 0.091 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.106605e-01 | 0.091 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.154099e-01 | 0.089 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.169900e-01 | 0.088 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.170562e-01 | 0.088 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.171143e-01 | 0.088 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.171143e-01 | 0.088 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.171143e-01 | 0.088 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.171143e-01 | 0.088 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.171143e-01 | 0.088 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.171143e-01 | 0.088 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.171143e-01 | 0.088 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.171143e-01 | 0.088 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.173916e-01 | 0.088 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.192201e-01 | 0.087 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.192201e-01 | 0.087 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.192201e-01 | 0.087 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.259981e-01 | 0.083 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.273667e-01 | 0.082 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.277107e-01 | 0.082 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.277107e-01 | 0.082 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.299482e-01 | 0.081 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.300419e-01 | 0.081 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.300419e-01 | 0.081 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.300419e-01 | 0.081 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.335954e-01 | 0.079 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.335954e-01 | 0.079 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.335954e-01 | 0.079 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.335954e-01 | 0.079 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.335954e-01 | 0.079 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.335954e-01 | 0.079 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 8.335954e-01 | 0.079 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.401250e-01 | 0.076 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.401250e-01 | 0.076 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.411147e-01 | 0.075 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.418963e-01 | 0.075 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.418963e-01 | 0.075 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.418963e-01 | 0.075 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.425181e-01 | 0.074 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.449828e-01 | 0.073 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.485921e-01 | 0.071 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.485921e-01 | 0.071 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.485921e-01 | 0.071 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.485921e-01 | 0.071 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.526086e-01 | 0.069 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.529954e-01 | 0.069 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.529954e-01 | 0.069 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 8.622380e-01 | 0.064 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.622380e-01 | 0.064 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.622380e-01 | 0.064 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.622380e-01 | 0.064 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.622380e-01 | 0.064 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.622380e-01 | 0.064 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.622380e-01 | 0.064 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.622380e-01 | 0.064 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.622380e-01 | 0.064 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.622380e-01 | 0.064 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.622380e-01 | 0.064 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.633791e-01 | 0.064 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.633791e-01 | 0.064 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.660001e-01 | 0.062 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.665803e-01 | 0.062 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.675490e-01 | 0.062 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.675490e-01 | 0.062 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.678860e-01 | 0.062 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.730861e-01 | 0.059 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.746549e-01 | 0.058 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.746549e-01 | 0.058 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.746549e-01 | 0.058 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.746549e-01 | 0.058 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.746549e-01 | 0.058 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.747340e-01 | 0.058 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.756821e-01 | 0.058 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.756821e-01 | 0.058 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.757223e-01 | 0.058 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.764624e-01 | 0.057 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.772011e-01 | 0.057 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.784947e-01 | 0.056 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.806481e-01 | 0.055 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.821539e-01 | 0.054 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.821539e-01 | 0.054 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.821539e-01 | 0.054 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.852356e-01 | 0.053 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.859532e-01 | 0.053 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.859532e-01 | 0.053 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 8.859532e-01 | 0.053 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.859532e-01 | 0.053 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.859532e-01 | 0.053 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.859532e-01 | 0.053 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.859532e-01 | 0.053 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.882394e-01 | 0.051 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.906190e-01 | 0.050 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.906190e-01 | 0.050 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.906190e-01 | 0.050 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.906190e-01 | 0.050 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.907910e-01 | 0.050 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.922993e-01 | 0.049 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.962338e-01 | 0.048 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.962338e-01 | 0.048 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.962338e-01 | 0.048 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.962338e-01 | 0.048 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.976168e-01 | 0.047 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.976681e-01 | 0.047 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.985163e-01 | 0.046 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.985163e-01 | 0.046 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.985163e-01 | 0.046 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.006550e-01 | 0.045 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.055882e-01 | 0.043 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.055882e-01 | 0.043 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.055882e-01 | 0.043 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.055882e-01 | 0.043 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.058793e-01 | 0.043 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.058793e-01 | 0.043 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.072192e-01 | 0.042 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.073265e-01 | 0.042 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.076363e-01 | 0.042 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.085484e-01 | 0.042 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.085484e-01 | 0.042 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.136201e-01 | 0.039 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.140998e-01 | 0.039 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.140998e-01 | 0.039 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.140998e-01 | 0.039 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.154744e-01 | 0.038 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.191295e-01 | 0.037 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.218445e-01 | 0.035 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.218445e-01 | 0.035 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.218445e-01 | 0.035 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.218445e-01 | 0.035 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.218445e-01 | 0.035 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.218445e-01 | 0.035 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.218445e-01 | 0.035 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.247362e-01 | 0.034 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.247362e-01 | 0.034 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.247362e-01 | 0.034 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.250766e-01 | 0.034 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.254425e-01 | 0.034 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.260359e-01 | 0.033 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.288913e-01 | 0.032 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.288913e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.288913e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.288913e-01 | 0.032 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.288913e-01 | 0.032 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.288913e-01 | 0.032 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.288913e-01 | 0.032 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.288913e-01 | 0.032 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.288913e-01 | 0.032 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.288913e-01 | 0.032 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.298224e-01 | 0.032 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.306092e-01 | 0.031 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.306092e-01 | 0.031 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.312561e-01 | 0.031 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.353032e-01 | 0.029 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.353032e-01 | 0.029 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.353032e-01 | 0.029 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.353032e-01 | 0.029 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.357537e-01 | 0.029 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.357537e-01 | 0.029 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.357876e-01 | 0.029 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.394015e-01 | 0.027 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.405351e-01 | 0.027 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.405351e-01 | 0.027 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.411373e-01 | 0.026 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.411373e-01 | 0.026 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.449769e-01 | 0.025 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.449769e-01 | 0.025 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.449769e-01 | 0.025 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.449769e-01 | 0.025 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.464455e-01 | 0.024 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.464455e-01 | 0.024 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.464455e-01 | 0.024 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.473797e-01 | 0.023 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.477118e-01 | 0.023 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.477118e-01 | 0.023 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.512049e-01 | 0.022 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.512754e-01 | 0.022 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.512754e-01 | 0.022 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.512754e-01 | 0.022 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.512754e-01 | 0.022 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.512754e-01 | 0.022 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.528639e-01 | 0.021 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.529302e-01 | 0.021 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.545391e-01 | 0.020 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.556699e-01 | 0.020 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.556699e-01 | 0.020 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.556699e-01 | 0.020 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.556699e-01 | 0.020 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.556699e-01 | 0.020 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.564826e-01 | 0.019 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.575471e-01 | 0.019 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.596684e-01 | 0.018 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.596684e-01 | 0.018 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.597773e-01 | 0.018 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.604203e-01 | 0.018 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.604203e-01 | 0.018 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.610907e-01 | 0.017 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.628320e-01 | 0.016 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.628320e-01 | 0.016 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.631428e-01 | 0.016 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.633064e-01 | 0.016 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.633064e-01 | 0.016 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.637721e-01 | 0.016 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.657327e-01 | 0.015 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.666164e-01 | 0.015 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.666164e-01 | 0.015 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.666164e-01 | 0.015 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.670838e-01 | 0.015 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.683031e-01 | 0.014 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.696280e-01 | 0.013 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.696280e-01 | 0.013 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.696280e-01 | 0.013 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.723681e-01 | 0.012 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.723681e-01 | 0.012 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.723681e-01 | 0.012 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.729651e-01 | 0.012 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.741629e-01 | 0.011 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.748285e-01 | 0.011 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.748612e-01 | 0.011 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.748612e-01 | 0.011 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.787560e-01 | 0.009 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.791931e-01 | 0.009 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.791931e-01 | 0.009 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.810707e-01 | 0.008 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.810707e-01 | 0.008 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.819281e-01 | 0.008 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.819281e-01 | 0.008 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.820349e-01 | 0.008 | 0 | 0 |
| Translation | R-HSA-72766 | 9.823376e-01 | 0.008 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.827790e-01 | 0.008 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.827790e-01 | 0.008 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.827790e-01 | 0.008 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.827790e-01 | 0.008 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.827790e-01 | 0.008 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.827790e-01 | 0.008 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.828930e-01 | 0.007 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.832081e-01 | 0.007 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.835952e-01 | 0.007 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.840728e-01 | 0.007 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.843332e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.843332e-01 | 0.007 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.843332e-01 | 0.007 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.843332e-01 | 0.007 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.843332e-01 | 0.007 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.857472e-01 | 0.006 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.857520e-01 | 0.006 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.866065e-01 | 0.006 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.869515e-01 | 0.006 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.870337e-01 | 0.006 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.879771e-01 | 0.005 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.882041e-01 | 0.005 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.887241e-01 | 0.005 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.888937e-01 | 0.005 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.889240e-01 | 0.005 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.889240e-01 | 0.005 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.892689e-01 | 0.005 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.902377e-01 | 0.004 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.905140e-01 | 0.004 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.911191e-01 | 0.004 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.919209e-01 | 0.004 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.926504e-01 | 0.003 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.926504e-01 | 0.003 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.926504e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.926680e-01 | 0.003 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.932517e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.932517e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.933141e-01 | 0.003 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.933141e-01 | 0.003 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.934721e-01 | 0.003 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.936275e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.936275e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.936772e-01 | 0.003 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.947429e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.947429e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.949668e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.951641e-01 | 0.002 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.951641e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.953415e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.954214e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.954214e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.955521e-01 | 0.002 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.955937e-01 | 0.002 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.958282e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.962112e-01 | 0.002 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.962112e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.968320e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.970837e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.973141e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.974910e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.975317e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.978534e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.978539e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.979161e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.980156e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.980452e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.980452e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.981881e-01 | 0.001 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.982239e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.983844e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.983844e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.983844e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.985304e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.986632e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.987765e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.987841e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.988940e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.988945e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.991279e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.991677e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.992328e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.994303e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.994697e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.994818e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.994863e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.995713e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.997066e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.998031e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.998290e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998340e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.998607e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.998983e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999096e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999145e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999415e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999454e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999560e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999600e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999669e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999704e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999794e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999825e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999834e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999894e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999904e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999913e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999916e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999958e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999961e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999965e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999977e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999981e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999987e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999988e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999988e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999993e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999996e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999997e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999999e-01 | 0.000 | 1 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |